NOVEL POLYPEPTIDES AND POLYNUCLEOTIDES RELATING TO THE alpha - and beta -SUBUNITS OF GLUTAMATE DEHYDROGENASES AND METHODS OF USE

Abstract: Amino acid and nucleotide sequences relating to the glutamate dehydrogenase (GDH) enzyme are described. The GDH enzymes described herein were discovered in the alga Chlorella sorokiniana in the form of seven different inducible isoenzymes. These isoenzymes are found in the algae as chloroplast-localized hexamers composed of alpha- and beta-subunits. Plants transformed with nucleotide sequences encoding the alpha- or beta-subunits of the enzyme show improved properties, for example, increased growth and improved stress tolerance. A heterohexamer having both alpha - and beta -subunits can have higher aminating:deaminating activity ratio than alpha -homohexamers or beta -homohexamers.

Description: DESCRIPTION NOVEL POLYPEPTIDES AND POLYNUCLEOTIDES RELATING TO THE a- AND fi-SUBUNITS OF GLUTAMATE DEHYDROGENASES AND METHODS OF USE This invention was made with government support under USDA Competitive Grant Number 87-CRCR-1-2476. The government has certain rights in this invention. Cross-Reference to a Related Application This application is a continuation-in-part of co-pending application Serial No.08/541,033, filed October 6, 1995. Background of the Invention Inorganic nitrogen acquired by plants is ultimately converted to ammomum before being assimilated in organic nitrogen metabolism. One enzyme postulated to be involved in the assimilatory process is glutamate dehydrogenase (GDH), a group of ubiquitous enzymes found to be present in almost all organisms from microbes to higher plants and animals (Srivastava, H.S., R.P. Singh [1987] Phytochem. 26:597-610). GDH catalyses the reversible conversion of a- ketoglutarate to glutamate via a reductive amination that utilizes reduced ?-nicotinamide adenine dinucleotide (NADH) or reduced ^-nicotinamide adenine dinucleotide phosphate (NADPH) as a cofactor. The role of plant GDHs in the assimilation of ammonium into amino acids has been questioned since the discovery of the glutamine synthetase/glutamate synthase (GS/GOGAT) pathway that is believed to be the favored pathway for ammomum assimilation in higher plants (Miflin, B.J., PJ. Lea [1976] Phytochem. 15:873-885). The primary objection to GDH playing a major role in plant nitrogen metabolism is its low affinity for ammomum that would require high intracellular ammonium concentrations to function anabolically. Early evidence indicated that GDH is a catabolic enzyme catalyzing the deamination of glutamate with only a partially anabolic function in synthesizing glutamate (Wallgrove, J.C, N.P. Hall, A.C. Kendall, [1987] Plant PhysioL 83:155-158). The physiological role of large amounts of GDH present in various plant tissues and organelles is still unclear, and possible conditions under which GDH may play a significant role in carbon and nitrogen metabolism have not been resolved. The majority of plant GDHs characterized to date are localized in the mitochondria; however, a GDH species differing in several properties (e.g., cofactor specificity, K^. values, organelle localization, thermal stability, among others) has been characterized from the chloroplast of a unicellular green alga Chlorella sorokiniana. C. sorokiniana cells have been shown to possess a constitutive, mitochondria!, tetrameric NAD-specific GDH (hereinafter designated "NAD-GDH") (Meredith, MJ., R.M. Gronostajski, R.R. Schmidt [1978] Plant PhysioL 61:967- 974), and seven ammonium-inducible, chloroplast-localized, homo- and heterohexameric NADP- specific GDH isoenzymes (hereinafter designated "NADP-GDH")(Prunkard, D.E., N.F. Bascomb, R.W. Robinson, R.R. Schmidt [1986] Plant PhysioL 81:349-355; Bascomb, N.F., R.R. Schmidt [1987] Plant PhysioL 83:75-84). The seven chloroplastic NADP-GDH isoenzymes were shown to have different electrophoretic mobilities during native-PAGE, which can result from the formation of homo- and heterohexamers composed of varying ratios of a- and S-subunits (53.5 and 52.3 kilodaltons, respectively). Chlorella cells cultured in 1 to 2 mM ammonium medium accumulate only the a- homohexamer (Bascomb and Schmidt, supra). The addition of higher ammonium concentrations (3.4 to 29 mM) to nitrate-cultured cells results in the accumulation of both a- and ^-subunits in NADP-GDH holoenzymes (Prunkard et aL, supra; Bascomb and Schmidt, supra; Bascomb, N.F., D.E. Prunkard, R.R. Schmidt [1987] Plant PhysioL 83:85-91). Prunkard et aL (Prunkard, D.E., N.F. Bascomb, NF, W.T. Molin, R.R. Schmidt [1986] Plant PhysioL 81:413-422) demonstrated that the NADP-GDH subunit ratio and isoenzyme pattern is influenced by both the carbon and nitrogen source as well as the light conditions under which cells are cultured. The a- and -NADP-GDH homohexamers purified from Chlorella cells have strikingly different ammomum K^ values; however, the 1^ values for their other substrates are very similar. The α-homohexamer (composed of six identical α -subunits) that catalyzes the biosynthesis of glutamate is allosterically regulated by NADPH and possesses an unusually low K , for ammomum that ranges from 0.02 to 3.5 mM, depending on the NADPH concentration (Bascomb and Schmidt, supra). The K g , value for ammomum of the α-homohexamer is the lowest reported ammonium K^ for any plant GDH characterized to date. In contrast, the /3-homohexamer (catabolic foπn) is a non-allosteric enzyme with an ammonium K^. of approximately 75 mM. From these studies involving purified enzymes, it had been heretofore postulated that the heterohexamers have varying degrees of affinity for ammomum ranging between the K^ values for the a- and 3-homohexamers. Surprisingly, however, we have discovered that certain heterohexamers can have aminating:deaminating activity ratio which is greater than either the a- or /..-homohexamers. Although the a- and 2-subunits have distinct in vivo turnover rates (Bascomb et aL, supra) and the corresponding homohexamers have remarkably different ammonium K^ values, the a- and/S-subunits are derived from precursor proteins of nearly identical size (ca 58,000 Daltons) and were shown to have very similar peptide maps (Prunkard et aL, supra; Bascomb and Schmidt, supra). Moreover, polyclonal antibodies prepared against the ?-homohexamer are capable of immunoprecipitating all ofthe NADP-GDH isoenzymes (Yeung, AT., KJ. Turner, RF. Bascomb, R.R. Schmidt [1981] AnaL Biochem. 10:216-228; Bascomb et aL, supra), but do not crossreact with the mitochondrial NAD-GDH. In addition, previous research in this laboratory provided genomic cloning and southern blot evidence that indicated the C. sorokiniana genome possesses a single NADP-GDH structural gene (Cock, J.M., K.D. Kim, P.W. Miller, R.G. Hutson, R.R. Schmidt [1991] Plant MoL BioL 17:17-27). The C. sorokiniana nuclear-encoded chloroplastic NADP-GDH isoenzymes are the only chloroplastic localized GDH sequences isolated and characterized from plants. Although the Chlorella GDH isoenzymes had been previously characterized, it has been discovered in the present invention that the two mature subunits arise via specific processing of two similar precursor proteins encoded by two mRNAs formed by alternative splicing of a pre-mRNA derived from a single nuclear gene. Furthermore, the identification of the cleavage site and amino- terminal peptide sequence of the mature functional GDH subunits had not been accomplished prior to the present invention. Brief Summary of the Invention The present invention provides the isolation and characterization of two full-length cDNAs from mRNAs isolated from the unicellular green algae Chlorella sorokiniana. The two cDNAs encode the precursor proteins (α-precursor, 56.35 kD; S-precursor, 57.85 kD) that are processed to yield the mature a- and 7-subunits (53.5 kD; 52.3 kD, respectively) that compose the active NADP-GDH hexameric isoenzymes. The present invention concerns a single NADP- GDH gene which is alternatively spliced to yield two mRNAs that encode two different chloroplast precursor proteins. These precursor proteins can then be processed to the mature a- and/9-subunits of the NADP-GDH isoenzymes. Also described are useful fragments or mutants of the nucleotide and amino acid sequences which retain the disclosed activity or utility. For example, certain fragments of the amino acid sequences provided herein can be useful as transit peptides, providing the protein with the capability to enter and remain in certain cell compartments. The nucleotide sequences which are described herein, and fragments of those nucleotide sequences, can be useful, for example, as primers in amplification procedures or as probes to hybridize to complementary sequences of interest. The nucleotide and amino acid sequences and fragments thereof as described herein can also be useful as molecular weight markers or in identifying and conforming the relatedness of other nucleotide sequences, polypeptides, or isoenzymes which pertain to NADP-GDH. The present invention further provides methods in which assimilation of inorganic nitrogen into organic nitrogen metabolism of higher plants can be altered by expressing GDH from C. sorokiniana or GDHs isolated from other organisms. The alteration of nitrogen assimilation can have the effect of increasing nitrogen assimilation which, as is well understood in the art, can affect the composition of the plant through an inverse effect on carbon metabolism, e.g., accumulation of carbohydrates. The subject invention also concerns DNA constructs for use in the described methods. The present invention includes the identification of the amino-terminal sequences of the a- and ^-subunits which can assemble to form NADP-GDH isoenzymes, e.g., the native hexameric NADP-GDH found in C. sorokiniana chloroplasts. This precise molecular infoπnation can be employed to express NADP-GDH with the unique kinetic properties of the C. sorokiniana chloroplastic α- and J-NADP-GDH homohexamers. The present invention also provides recombinant cells or organisms, e.g., transgenic crops or plants which, by expressing the genes of the described polynucleotide sequences to produce coπesponding polypeptides, can have an increased yield, improved ammonia assimilatory properties which can advantageously increase their tolerance of ammonia toxicity, improved osmotic stress tolerance, and improved composition of the crop or plant. Brief Description of the Drawings Figure 1 shows a pattern of NADP-GDH activities in homogenates of synchronous C. sorokiniana cells cultured for 240 min in 29 mM ammomum medium in continuous light. Aliquots of clarified homogenates, from cell collected at various time intervals, were analyzed spectrophotometrically for both aminating (•) and deaminating (o) NADP-GDH activities. Figure 2 shows patterns of accumulation of NADP-GDH antigens in illuminated cells cultured in 29 mM ammonium medium for 240 min. At zero time, ammomum was added to synchronous C. sorokiniana daughter cells and the culture was illuminated. Autoradiographs of Western blots were analyzed by laser densitometry to determine the relative levels of the NADP- GDH α-subunit (•) and 3-subunit (o) throughout the 240 min induction period. Brief Description of the Sequences SEQ ID NO. 1 is the cDNA for the precursor-protein of the α-subunit of an NADP- specific glutamate dehydrogenase. SEQ ID NO. 2 is the deduced amino acid sequence of the polynucleotide of SEQ ID NO. 1. SEQ ID NO. 3 is the cDNA for the precursor-protein of the /3-subunit of an NADP- specific glutamate dehydrogenase. SEQ ID NO.4 is the deduced amino acid sequence of the polynucleotide of SEQ ID NO. 3. SEQ ID NO. 5 is the N-terminal sequence for the NADP-GDH α-subunit. SEQ ID NO. 6 is the N-terminal sequence for the NADP-GDH β-subvaύl. SEQ ID NO. 7 is the cDNA sequence in the clone designated pBGDc53. SEQ ID NO. 8 is a primer which hybridizes to the conserved region of NADP-GDH mRNAs. SEQ ID NO.9 is a poly(dT) polynucleotide used as an adaptor primer according to the subject invention. SEQ ID NO. 10 is a polynucleotide used as a primer according to the subject invention. SEQ ID NO. 11 is a polynucleotide used as a primer according to the subject invention. SEQ ID NO. 12 is a polynucleotide used as an adaptor primer according to the subject invention. SEQ ID NO. 13 is the polynucleotide insert in the clone designated pRGDc 60. SEQ ID NO. 14 is the polynucleotide insert in the clone designated pRGDc 61. SEQ ED NO. 15 is the polynucleotide used as a primer according to the subject invention. SEQ ID NO. 16 is the polynucleotide insert in a clone designated pGDc 63. SEQ LD NO. 17 is the polynucleotide insert of a clone designated pGDc 64. SEQ ID NO. 18 is the polynucleotide resulting from ligation of purified fragments of the inserts in the clones designated pBGDc 53 and pGDc 63, according to the subjeα invention. SEQ ID NO. 19 is the polynucleotide resulting from ligation of purified inserts of the clones designated pGDc 64 and pBGDc 53. SEQ LD NO. 20 is a polynucleotide used as a primer according to the subjeα invention. SEQ ID NO.21 is a polynucleotide used as a primer hybridizing to the 3' terminus of the template DNA according to the subject invention. SEQ ID NO. 22 is a polynucleotide used as a primer according to the subject invention. SEQ ID NO.23 is the polynucleotide sequence (cDNA) of the processed, mature NADP- GDH α-subunit. SEQ ID NO. 24 is the amino acid sequence of the processed, mature NADP-GDH α- subunit. SEQ ID NO.25 is the polynucleotide (cDNA) sequence of the processed, mature NADP- GDH p'-subunit. SEQ ID NO. 26 is the amino acid sequence of the processed, mature NADP-GDH β- subunit. Detailed Disclosure of the Invention The present invention provides heretofore undescribed polynucleotide sequences, for example, cDNAs for precursor-proteins of α- and /3-subunits of an ammomum inducible, chloroplast-localized NADP-specific glutamate dehydrogenase (hereinafter NADP-GDH) from Chlorella sorokiniana. The nucleotide sequences for the precursor proteins of the α- and β- subunits that form NADP-GDH are shown in SEQ ID NOS. 1 and 3, respeαively. The deduced amino acid sequences for the precursor-proteins of the α- and ?-subunits of tiie NADP-GDH enzyme from Chlorella sorokiniana are shown in SEQ ID NOS. 2 and 4, respectively. E. coli hosts comprising the subject cDNA inserts were deposited with the American Type Culture Collection (ATCC), 12301 Parklawn Drive, Rockville, Maiyland 20852 USA The cultures were assigned the following accession numbers by the repository: Culture Accession number Deposit date E. coli DH5α ATCC 69925 October 6, 1995 α-NADP-GDH SEQ No. 1 (+42 bp) E. coli DH5α ATCC 69926 Oαober 6, 1995 S-NADP-GDH SEQ No. 1 (-42 bp) The subjeα cultures have been deposited under conditions that assure that access to the culture(s) will be available during the pendency of this patent application to one determined by the Commissioner of Patents and Trademarks to be entitled thereto under 37 CFR 1.14 and 35 USC 122. The deposits are available as required by foreign patent laws in countries wherein counterparts of the subject application, or its progeny, are filed. However, it should be understood that the availability of a deposit does not constitute a license to practice the subject invention in derogation of patent rights granted by governmental action. Further, the subject culture deposits will be stored and made available to the public in accord with the provisions of the Budapest Treaty for the Deposit of Microorganisms, i.e., they will be stored with all the care necessary to keep them viable and uncontaminated for a period of at least five years after the most recent request for the furnishing of a sample of a deposit(s), and in any case, for a period of at least 30 (thirty) years after the date of deposit or for the enforceable life of any patent which may issue disclosing the cultures. The depositor acknowledges the duty to replace the deposit(s) should the depository be unable to furnish a sample when requested, due to the condition of the deposit(s). All restrictions on the availability to the public of the subject culture deposits will be irrevocably removed upon the granting of a patent disclosing them. Automated amino acid sequence analysis identifies 20 and 10 amino-terminal amino acid residues of the α- and ^-subunits, respectively. Alignment of the α- and J-subunit peptide sequences reveals that the two subunits are identical with the exception of an 1 l-amino acid extension present in the larger α-subunit. Monoclonal antibodies raised against the α-subunit were shown to recognize the ? -subunit providing further evidence that the two subunits are nearly identical. The identification ofthe unique α- and /S -subunit processing sites within the precursor proteins provides the molecular mechanism to explain the different kinetic properties of the Gr¬ and /S-NADP-GDH homohexameric isoenzymes. The aforementioned data provide information applicable to genetically engineer plants with a specific GDH having favorable kinetic properties which can influence both carbon and nitrogen metabolism. Based on the high guanine/cytosine content the cDNAs are highly amenable for heterologous expression in higher plants. The introduction of either or both subunits with their chloroplast targeting sequences or with other organellar targeting sequences in heterologous plant systems can improve mtrogen assimilation and influence the carbon/nitrogen balance. It has been discovered that chloroplast localization is related to, and can be dependent on, the N-terminus of the α- or /^-precursor protein. Cleavage of the N-terminus of the precursors yields the mature proteins. Accordingly, the chloroplast transit peptide comprises a peptide which forms, or is an aαive fragment of, the N-terminus cleaved from the precursor protein. Peptides having similar or equivalent amino acid sequences, or that have a tertiary structure or conformation similar to these cleaved peptides can also function as transit peptides. The chloroplast-transit peptide comprises the active fragment of the N-terminal peptide cleaved from the α-precursor (a 40-mer) or the yS-precursor (a 37-mer). The polynucleotide sequences encoding the chloroplast-transit peptides can be used by persons of ordinary skill in the art to produce chloroplast-transit peptides employed with the peptides described herein, or others known in the art. Adding, removing, or replacing the chloroplast-transit peptide associated with a protein, e.g., the GDH enzyme, can be employed to localize the protein according to need, by means well known in the art. For example, localization of the enzyme in a chloroplast of a cell can be achieved by the insertion of a chloroplast-transit peptide onto an amino acid sequence lacking such a transit peptide. Species-specific chloroplast-transit peptides can be added or can replace those present to optimize insertion into the chloroplast of a desired species. In addition, localization inside the chloroplast of a protein expressed within the chloroplast can be achieved by direct transformation of the plastid with the polynucleotide sequences encoding an expressed protein. Similarly, removal of a chloroplast-transit peptide or production of a recombinant protein lacking the peptide can be utilized to sequester the protein in a cellular compartment other than tbe chloroplast. Transformed plants expressing the α-homohexamer can be more tolerant to ammonia toxicity, assimilate ammonium more efficiently, and respond more rapidly to osmotic stress encountered in transiently saline soils by providing glutamate the precursor to the osmoprotectant proline. Expression of, for example, thep'-homohexamer or GDH heterohexamers can be used to alter the rate of nitrogen assimilation, favoring accumulation of carbohydrates in fruits and other storage organs. Unexpectedly, it was discovered that a hexamer comprising at least one α-subunit and at least one }-subunit, i.e., a heterohexamer, can have advantageous aαivity. Specifically, the aminating:deaminating activity ratio (Le., biosynthetic capacity for synthesis of glutamate) of a chloroplastic NADP-GDH isozyme can be increased by incorporating both α- and .-subunits into the hexameric protein rather than using a homohexamer comprising only the α- or only the β- subunits. In one embodiment of the invention, it can be advantageous to co-express cDNAs encoding both types of subunits in the same plant at different rates/levels such that a particular ratio of α- and J-subunits is obtained in the heterohexamer. For example, we have discovered that an NADP-GDH heterohexamer having at least one of the subunits in the ϊ-form is prefeπed for increasing aminating:deaminating aαivity ratio. A more prefeπed heterohexamer has 2-5 β- subunits. This differential rate of expression of the two cDNAs can be accomplished by placing them under the control of plant promoters with different strengths or under the same promoter that has been modified to generate different levels of expression. The use of this algal NADP- GDH isozyme system in plant biotechnology has advantages over NADP-GDHs from organisms, such as bacteria, that contain only a single form of the enzyme (i.e., no isozymes). It is recognized that expression levels of certain recombinant proteins in transgenic plants can be improved via increased expression of stabilized mRNA transcripts; and that, conversely, detection of these stabilized RNA transcripts may be utilized to measure expression of translational produα (protein). Low expression of protein RNA in plants and, therefore, of low protein expression, can be resolved through the use of an improved, synthetic gene specifying the desired protein from the gene source organism. Thus, in one embodiment of the subject invention, bacteria and plants can be genetically engineered to attain desired expression levels of novel proteins having agricultural or otherwise commercial value. To provide genes having enhanced expression in plants, the DNA sequence of the gene can be modified to comprise codons prefeπed by highly expressed plant genes, to attain an A+T content in nucleotide base composition substantially that found in plants, and also preferably to form a plant initiation sequence, and to eliminate sequences that cause destabilization, inappropriate polyadenylation, degradation and termination of RNA and to avoid sequences that constitute secondary structure hairpins and RNA splice sites. For example, in synthetic genes, the codons used to specify a given amino acid can be selected with regard to the distribution frequency of codon usage employed in highly expressed plant genes to specify that amino acid. As is appreciated by those skilled in the art, the distribution frequency of codon usage utilized in the synthetic gene is a determinant of the level of expression. For purposes of the subjeα invention, "frequency of prefeπed codon usage" refers to the preference exhibited by a specific host cell in usage of nucleotide codons to specify a given amino acid. To determine the frequency of usage of a particular codon in a gene, the number of occurrences of that codon in the gene is divided by the total number of occurrences of all codons specifying the same amino acid in the gene. Similarly, the frequency of prefeπed codon usage exhibited by a host cell can be calculated by averaging frequency of prefeπed codon usage in a large number of genes expressed by the host cell. It is preferable that this analysis be limited to genes that are highly expressed by the host cell. When synthesizing a gene for improved expression in a host cell it is desirable to design the gene such that its frequency of codon usage approaches the frequency of prefeπed codon usage of the host cell. The percent deviation of the frequency of prefeπed codon usage for a synthetic gene from that employed by a host cell is calculated first by determining the percent deviation of the frequency of usage of a single codon from that of the host cell followed by obtaining the average deviation over all codons. As defined herein this calculation includes unique codons (i.e., ATG and TGG). In general terms the overall average deviation of the codon usage of a synthetic gene from that of a host cell is calculated using the equation where ^---frequency of usage for codon n in the host cell; Y n =frequency of usage for codon n in the synthetic gene. Where n represents an individual codon that specifies an amino acid, the total number of codons is Z. The overall deviation of the frequency of codon usage, for all amino acids should preferably be less than about 25%, and more preferably less than about 10%. Hence, a gene can be designed such that its distribution frequency of codon usage deviates, preferably, no more than 25% from that of highly expressed plant genes and, more preferably, no more than about 10%. In addition, consideration is given to the percentage G+C content of the degenerate third base (monocotyledons appear to favor G+C in this position, whereas dicotyledons do not). It is also recognized that the XCG (where X is A, T, C or G) nucleotide is the least prefeπed codon in dicots whereas the XT A codon is avoided in both monocots and dicots. Synthetic genes of this invention also preferably have CG and TA doublet avoidance indices closely approximating those of the chosen host plant. More preferably these indices deviate from that of the host by no more than about 10-15%. Assembly of the NADP-GDH gene of this invention can be performed using standard technology known in the art. A structural gene designed for enhanced expression in plants of the specific embodiment can be enzymatically assembled within a DNA vector from chemically synthesized oligonucleotide duplex segments. The gene can then be introduced into a plant host cell and expressed by means known to the art. Preferably, the protein produced upon expression of the synthetic gene in plants is functionally equivalent to a native protein in having comparable or improved aminating/deaminating activity. According to the subjeα invention, functionally equivalent refers to identity or near identity of function. A synthetic gene produα which has at least one property relating to its activity or function, which is the same or similar to a natural protein is considered functionally equivalent thereto. Modifications in nucleotide sequence of the coding region can be made to alter the A+T content in DNA base composition of a synthetic gene to reflect that normally found in genes for highly expressed proteins native to the host cell. Preferably the A+T content of the synthetic gene is substantially equal to that of said genes for highly expressed proteins. In genes encoding highly expressed plant proteins, the A+T content is approximately 55%. It is prefeπed that the synthetic gene have an A+T content near this value, and not sufficiently high as to cause destabilization of RNA and, therefore, lower the protein expression levels. More preferably, the A+T content is no more than about 60% and most preferably is about 55%. Also, for ultimate expression in plants, the synthetic gene nucleotide sequence preferably can be modified to form a plant initiation sequence at the 5' end of the coding region. In addition, particular attention is preferably given to assure that unique restriction sites are placed in strategic positions to allow efficient assembly of oligonucleotide segments during construction of the synthetic gene and to facilitate subsequent nucleotide modification. As a result of these modifications in coding region of the native gene, the prefeπed synthetic gene is expressed in plants at an enhanced level when compared to that observed with natural structural genes. It is known that the relative use of synonymous codons differs between the monocots and the dicots. In general, the most important factor in discriminating between monocot and dicot patterns of codon usage is the percentage G+C content of the degenerate third base. In monocots, 16 of 18 amino acids favor G+C in this position, while dicots only favor G+C in 7 of 18 amino acids. For soybean and maize, the maize codon usage pattern resembles that of monocots in general, whereas the soybean codon usage pattern is almost identical to the general dicot pattern. In designing a synthetic gene for expression in plants, it is prefeπed to eliminate sequences which interfere with the efficacy of gene expression. A synthetic gene may be synthesized for other purposes in addition to that of achieving enhanced levels of expression. For example, in accordance with the subject invention, one of the nucleotide sequences encoding the α-subunit or the S-subunit of NADP-GDH can be modified such that the products are differentially expressed, favoring expression of one of the subunits. A result of such differential expression is a heterohexamer comprising more of one subunit than the other. Modification may encompass substitution of one or more, but not all, of the oligonucleotide segments used to construct the synthetic gene by a coπesponding region of natural sequence. Preferably, differential expression of the nucleotide sequences encoding the α- and/3- subunits of the NADP-GDH polypeptides can be employed to produce a heterohexamer having at least one /S-subunit, more preferably two to five .-subunits, and most preferably three β- subunits. The recombinant DNA molecule comprising a nucleotide sequence of the subjeα invention can be introduced into plant tissue by any means known to those skilled in the art. The technique used for a given plant species or specific type of plant tissue depends on the known successful techniques. As novel means are developed for the stable insertion of foreign genes into plant cells and for manipulating the modified cells, skilled artisans will be able to select from known means to achieve a desired result. Means for introducing recombinant DNA into plant tissue include, but are not limited to, direct DNA uptake (Paszkowski, J. et al. (1984) EMBO J. 3:2717), electroporation (Fromm, M. et al. (1985) Proc. Natl. Acad. Sci. USA 82:5824), microinjection (Crossway, A et al. (1986) Mol. Gen. Genet. 202:179), or T-DNA mediated transfer from Agrobacterium tumefaciens to the plant tissue. There appears to be no fundamental limitation of T-DNA transformation to the natural host range of Agrobacterium. Successful T- DNA-mediated transformation of monocots (Hooykaas-Van Slogteren, G. et al. (1984) Nature 311:763), gymnospeπns (Dandekar, A et al. (1987) Biotechnology 5:587) and algae (Ausich, R., EPO application 108,580) has been reported. Representative T-DNA veαor systems are described in the following references: An, G. et al. (1985) EMBO J.4:277; Heπera-Estrella, L. et al. (1983) Nature 303:209; Heπera-Estrella, L. et al. (1983) EMBO J. 2:987; Heπera-Estrella, L. et al. (1985) in Plant Genetic Engineering, New York: Cambridge University Press, p. 63. Once introduced into the plant tissue, the expression of tbe structural gene may be assayed by any means known to the art, and expression may be measured as mRNA transcribed or as protein synthesized. Techniques are known for the in vitro culture of plant tissue, and in a number of cases, for regeneration in to whole plants. Procedures for transferring the introduced expression complex to commercially useful cultivars are known to those skilled in the art. In one of its prefeπed embodiments the invention disclosed herein comprises expression in plant cells of an NADP-GDH gene under control of a plant expressible promoter, that is to say, by inserting the gene into T-DNA under control of a plant expressible promoter and introducing the T-DNA containing the insert into a plant cell using known means. Once plant cells expressing the gene under control of a plant expressible promoter are obtained, plant tissues and whole plants can be regenerated therefrom using methods and techniques well-known in the art. The regenerated plants are then reproduced by conventional means and the introduced genes can be transfeπed to other strains and cultivars by conventional plant breeding techniques. The introduction and expression of the NADP-GDH gene can be used to improve, e.g., increase, yields in a crop. Other uses of the invention, exploiting the properties of the genes introduced into plant species will be readily apparent to those skilled in the art. Differences also exist between codon choice in plant nuclear genes and in cholorplasts. Chloroplasts differ from higher plants in that they encode only 30 tRNA species. Since chloroplasts have restricted their tRNA genes, the use of prefeπed codons by chloroplast-encoded proteins appears more extreme. However, a positive coπelation has been reported between the level of isoaccepting tRNA for a given amino acid and the frequency with which this codon is used in the chloroplast genome (Pfitzinger et al. (1987) Nucl. Acids Res. 15:1377-1386. In general, the chloroplast codon profile more closely resembles that of unicellular organisms, with a strong bias towards the use of A+T in the degenerate third base. Following are examples which illustrate procedures, including the best mode, for practicing the invention. These examples should not be construed as limiting. All percentages are by weight and all solvent mixture proportions are by volume unless otherwise noted. EXAMPLES Example 1 - Kinetics of C. sorokiniana Chloroplast Glutamate Dehvdropenases The chloroplastic glutamate dehydrogenase α- and p > -isoenzymes used in the following experiments are naturally produced by an organism characterized as Chlorella sorokiniana. C. sorokiniana culture conditions. For kinetic characterization in both the aminating and deaminating directions, the a- and/.-holoenzymes were purified from cells that were accumulating only one form of homohexameric GDH isoenzyme. The C. sorokiniana cells (UTEX-1230, University of Texas algal culture collection; 3B2NA Robert R. Schmidt, University of Florida, Microbiology Cell Science Department) were cultured autotrophically as previously described by Prunkard et aL, supra in a modified basal salts medium. The modified medium contained in mM concentration: CaCl 2 , 0.34; K 2 S0 4 6.0; KH 2 P0 4 , 18.4; MgCl 2 , 1.5; in μM concentration CoCl 2 , 0.189; CuCl 2 , 0.352; EDTA 72; FeCl 3 , 71.6; H 3 B0 3 , 38.8; MnCl 2 , 10.1; NH 4 V0 4 , 0.20; (NH 4 ) 6 M0 7 θ2 4 , 4.19; NiCl 2 , 0.19; SnCl 2 , 0.19; ZnCl 2 , 0.734. The medium was supplemented with 1 mM NH 4 C1, 29 mM NH 4 C1, or 29 mM KN0 3 as a nitrogen source depending on the experimental conditions. The medium containing NH 4 C1 was adjusted to pH 7.4, and medium containing KN0 3 was adjusted to pH 6.8 with KOH after autoclaving. Cells were supplied with a 2% (v v) C0 2 -air mixture and light intensity sufficient to allow cell division into four progeny. Purification of the NADP-GDH isoenzymes. For purification of the glutamate dehydrogenase α-isoenzyme, C. sorokiniana cells were cultured with continuous light in 29 mM ammonium medium in a 30 L Plexiglas chamber as previously described (Baker, AL., R.R. Schmidt [1963] Biochim. Biophys. Acta 74:75-83). Cells were harvested at 4.0 OD^ by centrifugation at 30,000 rpm through a Sharpies centrifuge and washed two times in 10 mM Tris (pH 8.5 at 4°C). Pelleted cells (130 g) were stored at -20°C in 250 mL centrifuge bottles until use. Purification of NADP-GDH was accomplished using a modified procedure of Yeung et aL, supra. Procedural modifications involved the substitution of Sephadex G-200 gel (Pharmacia) for G-150 gel in the gel-filtration column, and the addition of NADP + as a stabilizer to a final concentration of 0.1 mM to the gel-filtration buffer and all subsequent storage buffers. As a final modification, the NADP + affinity resin step was omitted and a preparative nondenaturing-PAGE step was substituted (Miller, P.W., W.D. Dunn, R.R. Schmidt [1994] BioRad US /EG Bulletin 1897). The GDH deaminating enzyme assay solution was composed of 44 mM Tris, 20.4 mM glutamate, and 1.02 mM NADP + , pH 8.8. The aminating assay solution was composed of 50 mM Tris, 25 mM α-ketoglutarate, 0.357 mM NADPH, and 0.356 M (NH 4 ) 2 S0 4 , pH 7.4. One unit of enzyme aαivity was the amount of NADP-GDH required to reduce or to oxidize 1.0 μmol of NADP + or NADPH per minute at 38.5°C. Sephadex G-200 column fractions possessing NADP-GDH activity were pooled and concentrated via Diafiow filtration. The soluble enzyme (68 mg) was protected from oxidation by the addition of DTT to a final concentration of 10 mM, and dialyzed for 30 minutes against 28.8 mM Tris, 192 mM glycine, 2 mM DTT (pH 8.4). The dialysate was clarified by centrifugation at 20,000g for 10 minutes at 4 C C and was combined with 3 mL of 40% (w/v) sucrose and 1 mL of 0.02% bromophenol blue. For preparative nondenaturing PAGE, a 3 cm tall 7% acrylamide (w/v, 28 acrylamide: 0.735 bis-acrylamide, pH 8.8) resolving gel, and a 2 cm tall 2% acrylamide (w/v, 1.6 acrylamide: 0.4 bis-acrylamide, pH 6.6) stacking gel were cast in the 28 mm ID gel tube of the Model 491 Prep Cell. All acrylamide stocks were pretreated with AG501-X8 mixed bed resin to remove any contaminating acrylic acid residue to prevent in vitro N-acylation of proteins during electrophoresis. The protein sample was eiectrophoresed at 15 mA constant power for 20 minutes and then for 3.5 hours at a constant power of 30 mA Six milliliter fractions were colleαed and assayed for NADP-GDH deaminating activity and GDH containing fractions were pooled. The enzyme in the pooled fractions in 10 mM KP0 4 (pH 6.2), 0.1 mM NADP + was concentrated by Diafiow ultrafiltration to 1 mg mL as determined by the method of Bradford, using BSA as a standard. The concentrated enzyme preparation was stored at -20°C. The purity of the preparation was determined by silver-staining to visualize proteins resolved by 10% (w/v) Tris- Tricine SDS-PAGE (Schagger, R, G. von Jagow [1987] AnaL Biochem. 166:368-379). The NADP-GDH ^-isoenzyme was purified from a mixture of cells cultured for 240 minutes in 1 mM ammomum medium (14 g), 90 minutes in 1 mM ammonium medium (6 g), and for 20, 40, 60, and 80 minutes in 29 mM ammonium medium (1 g/time point) according to Bascomb and Schmidt, supra. The NADP-GDH /9-isoenzyme was partially purified using a scaled down modified procedure of Yeung et aL, supra. The DEAE sephacel ion exchange columns (pH 7.4, and pH 6) were scaled down to a 40 mL bed volume and a 400 mL linear KCI gradient (0 to 0.4 M) was used to elute the proteins in 3 mL fractions. The pH 6 DEAE ion-exchange column fractions containing NADP-GDH were combined into two pools; coπesponding to the leading and trailing halves of the NADP-GDH aαivity peak. The separate pooled fraαions were dialyzed against 10 mM KP0 4 (pH 6.2), 2 mM DTT for 16 hours, and affinity purified using Type 3 NADP + affinity gel (Pharmacia) as previously described (Bascomb and Schmidt, supra). The NADP-GDH in the pooled fractions was concentrated via Diafiow ultrafiltration to 2 mg/ml protein, as determined by the method of Bradford (Bradford, MM. [1976] AnaL Biochem. 72:248- 254), and stored at 4°C until further use. After resolution of the proteins by 8% (w/v) Tris- Tricine SDS-PAGE, the purity of the preparation was determined by silver staining. Table 1 summarizes the K g , values determined for both the α- and J-homohexameric isoenzyme aminating reaction. Table 1 GDH Isoform Substrate 1^ Value (mM) α-homohexamer NADPH 0.14 NH 4 + 0.02-3.5 α-ketoglutarate °* 35 * /3-homohexamer NADPH 0.14 NH 4 + 77 α-ketoglutarate 12 *after Shatilov, V.R., W.L. Kretovich (1977) AfoZ. Cell Biochem. 15:201-212. Table 2 summarizes the K^ values determine for both the α- and .-homohexameric isoenzyme deaminating reaction. Table 2 GDH Isoform Substrate K Value (mM) α-homohexamer NADP+ 0.04 Glutamate 38.2 J-homohexamer NADP+ 0.04 Glutamate 32.3 Aαivitv of the α-. ^-heterohexamer. The aminating and deaminating activities of the mixture of native NADP-GDH isoenzymes (heterohexamers composed of varying ratios of the α- and/?-subunits) were also measured with saturating levels of substrates throughout the 240 minute induction period (Fig. 1). The aminating and deaminating activities showed initial induction lags of 20 to 40 min, respectively. The aminating activity increased rapidly during the first 100 min, deαeased sharply between 100 min and 140 min, and increased sharply once again between 140 min and 240 min. In contrast, the deaminating activity increased in almost a linear manner throughout the induction after the initial induction-lag. During the 240 min induction period in 29 mM ammonium medium, the patterns of accumulation of the Chlorella sorokiniana NADP-GDH α- and /S-subunits in isoenzymes were also examined by use of a western blot immunodetection procedure following SDS polyacrylamide-gel electrophoresis (see Fig.2). The NADP-GDH /5 -subunit was deteαed at T 0 and increased for the first 40 min followed by a gradual decrease through the remainder of the induction period. The α-subunit was first detected at 20 min. This subunit accumulated at a low rate for the first 80 min, showed a marked increase between 80 min and 100 min, and thereafter accumulated in a linear manner at a lower rate for the remainder of the induαion period. The transition from the J-subunit being the prominent species to the α-subunit being prominent occuπed between 60 and 80 min. The aminating:deaminating aαivity ratio and the aφ subunit ratio were calculated to determine if changes in the subunit ratio in the mixture of NADP-GDH isoenzymes conelated with the predicted aminating:deaminating activity ratio during the time-course of the induction period (Table 3). Surprisingly, the highest aminating:deaminating ratio was observed at 60 min when the subunit ratio showed the/S-subunit to be the prominent NADP-GDH antigen, whereas the α-subunit was the prominent form when the aminating:deaminating activity ratio was the lowest. This latter result was not predictable in advance. Prior to this discovery, substrate kinetic studies of purified α- andyS-homohexamers, the α-homohexamer, with its very high affinity for ammonium (relative to the J-homohexamer), was assumed to be the isoenzyme-form with the highest aminating aαivity (i.e., biosynthetic capacity for glutamate synthesis). The results suggested that the individual subunits would act independently with respeα to their kinetic properties in homo- and heterohexamers. Comparison of the aminating:deaminating activity ratio with the aβ subunit ratio throughout the 240 min induction in 29 mM ammomum medium revealed an unexpected correlation between the maxima in these ratios (Table 3). Table 3. NADP-GDH aminating :deaminating activity and α-subunit S-subunit ratios during ammonium induction period in C. sorokiniana cells. Table 3 Time (min) Am:Deam Activity a .β Subunit 0 2.87 0.28 20 2.96 0.58 40 3.81 0.49 60 4.51 0.80 80 3.49 1.57 100 2.73 8.74 140 1.61 11.23 The peak in aminating:deaminating ratio occuπed at 60 min at which time the /3-subunit was the prominent but not exclusive antigen, whereas the α-subunit was prominent when the aminating:deaminating ratio was lowest. Interestingly, the aminating aαivity was highest when both subunits were present, suggesting that heterohexamer(s), formed by combination^) of the α- and /S-subunits, can have a higher aminating activity than a homohexamer. Based on the much lower K , of tbe purified α-homohexamer that the .-homohexamer for ammomum, it had been predicted earlier that the α-homohexamer would have a higher aminating aαivity than any heterohexamer composed of the two subunits (Bascomb and Schmidt, 1987). Example 2 - Sequencing of Polypeptides and Polynucleotides Amino-terminal sequencing of the mature subunits. An aliquot of a preparation of purified NADP-GDH α-subunit (120 pmol) and a partially purified preparation of NADP-GDH α-subunit (80 pmol) and ^-subunit (50 pmol) were resolved by 8% (w/v) Tris-Tricine SDS-PAGE and electroblotted to a PVDF membrane (Immobilon-P SQ , Millipore) as described by Plough et aL (Plough, M. ( AL. Jensen, V. Barkholt [1989] Anal Biochem. 181:33-39). To prevent in vitro acylation of the protein amino-terminal residues, all polyacrylamide solutions used in PAGE were treated with AG501-X8 mixed bed resin to remove contaminating acrylic acid. An Applied Biosystems, Inc. model 470A gas phase sequencer was utilized for automated Edman degradation amino sequence analysis. The PTH-aa derivatives were identified by RP-HPLC. Protein sequence analysis of the electroblotted proteins was provided by the Interdisciplinary Center for Biotechnology Research Protein Chemistry Core facility at the University of Florida. The following N-terminal sequence was determined for the α-subunit: AVSLEEQISAMDATTGDFTA (SEQ ID NO. 5). The following N-terminal sequence was determined for the -subunit: DATTGDFTAL (SEQ ID NO. 6). These sequences are identical to the ORF identified in the two NADP-GDH cDNAs and indicate the positions of the internal cleavage sites utilized to remove the chloroplast targeting peptide sequences. The chloroplast targeting peptide sequences (or chloroplast-transit peptides) can be useful for cell compartment localization with these and other amino acid sequences. The polynucleotides encoding the chloroplast-transit peptides can be used with other polynucleotide sequences to encode chloroplast-transit peptides. cDNA isolation and sequencing. A pellet of C. sorokiniana cells stored at -70°C was resuspended 1 to 10 (w/v) in RNA breakage buffer: 0.1M Tris (pH8.5), 0.4M LiCl, 10 mM EGTA 5 mM EDTA 100 units/mL sodium heparin (Sigma, 100 units/mg), and 1 mM aurintricarboxylic acid (Sigma). The cell suspension was centrifuged at 7000 for 5 minutes at 4°C and the supernatant was discarded. The cell pellet was resuspended 1 to 10 (w/v) in RNA breakage buffer and ruptured by passage through a French pressure cell at 20,000 p.s.i. The cell homogenate was collected in a disposable 50 mL comeal tube containing 0.05 times volume 20% (w v) SDS, 0.05 times volume 0.5 M EDTA (pH 8), 200 //g/mL proteinase K, and allowed to incubate at room temperature for 15 minutes. One-half volume of TE buffer (Tris 10mM:EDTA ImM, pH 8.0) equilibrated phenol was added to the homogenate and after a 3 minutes incubation a one-half volume of chloroform:isoamylalcohol (24:l,v/v) was added and mixed for 10 minutes on a wrist action shaker. The extracted homogenate was transfeπed to a 30 mL siliconized corex tube and centrifuged at lOOug for 10 minutes at 4°C. The upper aqueous phase was removed and repeatedly extracted with an equal volume of chloroform: isoamyl-alcohol (24:1, v/v), as described above, until the aqueous interface was clear. After the final extraction, the aqueous phase was combined with an equal volume of 2X LiCl-Urea buffer (4 M LiCl, 4 M urea, 2 mM EDTA 1 mM aurintricarboxylic acid; Sigma) and the RNA was precipitated on ice for 16 hours at 4°C. The RNA precipitate was centrifuged at 4000g for 20 minutes at 4°C and the resulting pellet was rinsed once with IX LiCl-Urea buffer and centrifuged again to pellet the RNA The RNA pellet was solubilized in TE (pH 7.5) and an aliquot was quantified speαrophotometrically at 260 nm. After quantitation, the mRNA fraαion was isolated from total cellular RNA using an oligo(dT) spin column kit. Poly(A) + RNA (50 μg) from each preparation was combined and utilized for the commercial produαion of a custom AUni-ZAP XR C. sorokiniana cDNA library (Stratagene Cloning Systems, Palo Alto, CA). The amplified ΛZAP library, containing 2 x 10 10 pfu/mL, was plated on twenty 150 mm petri plates at 50,000 pfu per plate for a total of 1 x IO 6 pfu screened. The phage plaques were absorbed to duplicate Hybond-N 132 mm circular membranes and treated according to the plaque blotting protocol of Amersham (1985, Amersham International pic, Arlington Heights, IL ). Membranes were prehybridized in a common container in 200 mL of 2X PIPES (0.8 M NaCl, 20 mM PIPES, pH 6.5), 50% (w/v) formamide, 0.5% (w/v) SDS, 100 μg/mL denatured sheared salmon sperm DNA at 40°C. Blocked membranes were hybridized at 42°C in ten heat-sealable bags (four membranes/bag) in prehybridization buffer containing 1 x IO 6 cpm/membrane of a ^P- labeled NADP-GDH 242 bp HCR cDNA probe on a lab rocker. The membranes were washed three times in 200 mL of 0.1X SSC, 0.1% (w/v) SDS for 20 minutes per wash at 50°C Duplicate membranes were wrapped in plastic wrap and exposed to Kodak X-Omat AR film at -70°C for 28 hours. Putative NADP-GDH cDNA plaques, detected on duplicate membranes, were cored from the plate and plaque purified by secondary and tertiary screenings with the 242 bp conserved region probe. Putative NADP-GDH cDNA phage clones, selected in the primary screening, were combined and screened a second time with a 32 P-labeled 130 bp Eco RVBgl II cDNA fragment isolated from the 5' terminus of the most complete 5' end NADP-GDH cDNA clone. Ten plaque pure NADP-GDH clones were subcloned in pBluescript KS + (Stratagene) and transformed into E. coli DH5α F' (Bethesda Research Laboratories, BRL) via an in vivo excision protocol provided by Stratagene. All plasmid isolations were performed as described by Kraft et aL (Kraft, R., J. Tardiff, K.S. Krauter, L.A Leinwand [1988] Biotechniques 6:544-547). Sequence analysis revealed all ten clones were identical at their 3 '-termini and differed by varying degrees of truncation at their 5'-termini. The longest cDNA clone with a complete 3'-teπninus designated pBGDc53 (SEQ ID NO. 7) was not long enough to encode either subunit; therefore, the 5 '-terminal sequences were determined by RACE PCR. The 5 '-terminal NADP-GDH cDNA sequences were cloned using a modified anchored PCR procedure for the rapid amplification of cDNA ends (Frohman, M.A [1990] In D.H. Gelford, J J. Snincky, TJ. White, eds, PCR Protocols, Academic Press, San Diego, CA PP 28-38; Jain, R., R.H. Gorner, JJ. Murtagh [1992] Biotechniques 12:58-59). A mixture of poly(A) + RNA used in the synthesis of the AZAP library, was utilized to clone the 5' end of the NADP-GDH mRNA One hundred nanograms of the mRNA mixture were combined with 10 ng of a gene- specific primer (5'-CTCAAAGGCAAGGAACTTCATG-3', SEQ ID NO.8), designed to hybridize to the conserved region of NADP-GDH mRNAs, heated for 5 minutes, and chilled on ice. First strand DNA synthesis was performed using Superscript™ reverse transcriptase (BRL) according to the supplier's protocol. The terminated reverse transcription reaction was treated with one unit of ribonuclease H for 20 minutes at 37°C, 5 minutes at 95°C, and extracted once with chloroform:isoamyl alcohol (24:1, v/v). Excess primers and dNTPs were removed by centrifugation at 2000 rpm through an Ultrafree-MC filterfuge tube (30,000 MW cutoff, Millipore) and the retentate was concentrated to 10 μl on a Savant Speedvac. The first-strand synthesis products were combined with 10 μL of tailing mix (IX tailing buffer [Promega Corp.], 0.4 mM dATP, 10 units terminal deoxytransferase) and incubated at 37°C for 10 minutes. The reaction mixture was heated to 95°C for 5 minutes, diluted to 0.5 mL with TE (pH 8), and utilized as a cDNA pool. A mixture of 5μL of the cDNA pool, 5 μL of Vent™ polymerase 10X buffer (New England Biolabs), 200 μM of each dNTP, 25 pmol of a gene specific primer (SEQ LD NO. 8), 5 pmol of the poly(dT) adaptor primer (5'-GGGTCGACATTCTAGACAGAATTCGTGGATCC(T) 18 -3'; SEQ ID NO. 9), 0.2 units Perfectmatch™ DNA polymerase enhancer (Stratagene), and 1 unit of Vent™ polymerase (NEB) in 50 μL was amplified according to Jain et aL, supra. The PCR products were purified away from the excess primers by centrifugation at 2,000 rpm through an Ultrafree-MC unit. The retentate was collected and subjeαed to two more rounds of amplification using a new nested gene specific primer at each step (5'- GGACGAGTACTGCACGC-3', SEQ ID NO. 10; 5'-GATCTCGGTCAGCAGCTG-3\ SEQ ED NO. 11, respectively) and an adaptor primer (5'-GGGTCGACATTCTAGACAGAA-3'; SEQ ID NO. 12). PCR amplifications were performed in a Model 480 thermocycler (Perkin-Elmer Cetus), and all custom oiigonucleotides were synthesized by the ICBR DNA synthesis facility, University of Florida. The standard PCR reaαion mixture consisted of 10 μL of 10X Vent™ polymerase buffer, 100 μM of each dNTP, 0.4 units of Perfectmatch™, 50 pmol of each primer, 1 unit Vent™ DNA polymerase in a 100 μl reaction volume. The 5' RACE-PCR products were gel purified, subcloned into the Smal site of pUC 18, and transformed into E. coli DH5α for further characterization. RACE PCR identified two 5' cDNA clones, which overlapped with the previously identified pBGDc 53 clone, that differed by a 42 nt insert identified in one clone designated pRGDc 60 (SEQ ID NO. 13) and lacking in the second cDNA designated pRGDc 61 (SEQ ID NO. 14). Two additional cDNA clones lacking the RACE PCR polylinker, but possessing the complete 5'-teπnini coπesponding to pRGDc 60 and 61 were constructed by RT-PCR amplification from mRNA using reaction conditions as described above and the gene specific primer pair (5'-CTTTCTGCTCGCCCTCTC-3', SEQ ID NO. 15, and SEQ ID NO. 11, above). The two PCR products were cloned into the Smal site of pBluescript SK+ (Stratagene) and transformed into E. coli DH5α for further characterization. The cDNA clone that possessed the 42 nt insert was designated pGDc 63 (SEQ ID NO. 16) whereas the cDNA lacking the insert was designated pGDc 64 (SEQ ID NO. 17). Full-length NADP-GDH cDNAs were constructed by restriction endonuclease treating pGDc 63 and 64 with EcόRVApalA and gel purifying the resultant (264 bp; 222 bp, respeαively) fragments. The gel purified fragments were ligated to a purified ApalΛJXhol restriαion fragment of pBGDc 53 and the full length ligation products (SEQ ID NO. 18; SEQ ID NO. 19) were gel agarose gel purified and utilized in subsequent PCR reactions. Expression of α- and .-homohexamers in E. coli. Using the gel purified product (SEQ ID NO. 18), PCR mutagenesis was performed to remove the chloroplast targeting signal from the full-length cDNA and yield cDNAs encoding specifically the mature α- and /S-subunits. Two sets of primer pairs were designed to synthesize α- and p'-GDH subunit genes. The following primer was designed to add a methionine to the amino terminus of the processed mature α-NADP-GDH subunit (alanine-41) to allow translation initiation and to generate a 5' Ndel site for subcloning purposes: 5'-CATATGGCCGTCTCGCTGGAGGAG-3' (SEQ ID NO. 20). The following second primer was designed to hybridize to the 3' terminus of the template DNA at a position 20 nt 3' of the endogenous TAA termination codon: 5'- GTTGGATTGCCGGTGAGCC-3' (SEQ LD NO. 21). The following primer was designed to add a methionine to the amino terminus of the processed mature /..-subunit (aspartate-38) to allow translation initiation and to generate a 5' Ndel site for subcloning purposes: 5'-CATATGGACGCCACCACCGGC-3' (SEQ ID NO. 22). The second 3' primer used in the PCR amplification was the 3 '-terminus primer (SEQ ID NO. 21) described for the α-subunit amplification. PCR cycling conditions were as follows: 95°C, 50 seconds; 64°C, 1 minute; 72°C, 1 minute 35 seconds (30 cycles). Primer, dNTP, Vent polymerase, and other reaction component concentrations were as previously described. The 1506 bp α-NADP-GDH subunit gene (SEQ ID NO.23) and 1473 bp $ * -GDH subunit gene (SEQ ID NO.25) PCR products were gel purified and given a 3' adenine nucleotide overhang by incubating the purified fragment with 100 μM dATP and Taq polymerase for 15 minutes at 72°C. The modified PCR products were cloned into the PCRII T/A cloning vector (Invitrogen) and transformed into competent E. coli cells. Clones bearing the inserts were selected by blue-white screening, plasmid purified, and digested with NdeVBam l to select for the proper orientation in the cloning veαor. The selected plasmids were restricted with Ndel and BamHI (BamHI site provided by veαor) and directionally cloned under the control of the PTG inducible T7 polymerase promoter of pET lla and pET 15b bacterial expression vectors (Novagen) linearized with NdeVBamHl, and transformed into DH5α. Transformants were sαeened by NdeVBamHl restriction analysis and clones possessing the properly oriented α- and ?-subunit cDNAs (SEQ ID NO. 23; SEQ ID NO. 25) were seleαed, plasmid purified, and transformed into E. coli BL21(DE3) for protein expression purposes. E. coli BL21(DE3) cells transformed with pET lla-α-cDNA and pET lla-ρ * -cDNA constructs were induced with 100 mM IPTG for 1 hour. Protein extracts from the induced cells were tested by enzyme analysis for NADP-GDH activity, and the denatured proteins were resolved by SDS gel electrophoresis, and visualized by coomassie staining. The proteins expressed by the mature α-subunit cDNA (SEQ ID NO. 23) and the ?-subunit cDNA (SEQ LD NO. 25) have the amino acid sequences shown in SEQ ID NO.24 (α-subunit) and SEQ ID NO.26 (β-subunit). The recombinant GDH subunits were verified by crossreactivity with rabbit aaύ-ChloreUa NADP-GDH antibodies. Under conditions not optimized for maximal induction, the E. coli cells, possessing the α- and β-GOH cDNAs and induced with EPTG, showed 60- and 7,000-fold increases in NADP- GDH aαivity relative to uninduced controls, respectively. The recombinant α- and β-NADP- GDHs are cuπently being analyzed to verify kinetic and biochemical properties. The over-expression and assembly of the C sorokiniana chloroplastic GDHs into active enzymes provides proof that the DNA constructs engineered via PCR are transcribed and translated into authentic proteins. The aforementioned constructs were then utilized for cytosolic expression of the algal GDHs in transgenic plants. Transformation of plants. A method for producing genetically transformed plants that express increased levels of a specific GDH requires the introduction of a double-stranded recombinant DNA molecule into the nuclear genome of a plant cell. The DNA molecule must (1) contain a structural DNA for the GDH enzyme being introduced into the plant cell; (2) possess a promoter which functions in plants to regulate the production of an RNA sequence in a constitutive or tissue-specific manner by RNA polymerase enzyme; and (3) have a 3'- untranslated region which functions to cause transeriptional termination and the addition of polyadenylated nucleotides to the 3' end of the RNA The resulting primary RNA molecule is subsequently processed in the nucleus, a process which involves the removal of intronic sequences and the addition of polyadenylate nucleotides to the 3' end of the mRNA Promoters which are useful in the present invention are those that can initiate transcription in a constitutive manner or in a tissue-specific manner where glutamate production or catabolism is desired. An example of a useful constitutive promoter is the CaMV enhanced 35S promoter that directs the synthesis of RNA in a tissue independent manner. Promoters which cause production of GDH specifically in seeds, stems, roots, leaves, or specific cell types in these tissues are useful in the present invention. For example, the seed-specific Phaseolin promoter is one such tissue-specific promoter. Thus native promoters for maize, wheat, barley, and rice may be obtained and used in the present invention as well as heterologous promoters from other organisms shown to funαion in a constitutive/tissue-specific manner. Introns. Generally, optimal expression in monocotyledonous plants is obtained when an intron sequence is inserted between the promoter sequence and the structural gene sequence. An example of such an intron sequence is the HSP 70 intron desαibed in WO 93/19189. Polvadenylation signal. The DNA constructs of the present invention can possess a 3' untranslated region which functions in plants to direα the addition of polyadenylate nucleotides to the 3' end of the RNA An example of a suitable 3' untranslated region is the polyadenylation signal of the Agrobacterium tumor inducing plasmid, i.e., nopaline synthatase (NOS) gene. Plastid targeting sequence. The DNA constructs of the present mvention can optionally contain a plastid targeting sequence. The plastid targeting sequence directs the import of the protein into the plastid, and is removed during importation. The plastid targeting sequence can be, but is not limited to, the native chloroplast targeting peptide (CTP) identified in the C. sorokiniana NADP-GDH full-length cDNAs which encode the precursor proteins. A fusion of a selected plastid targeting sequence and the mature α- andβ-NADP-GDH subunit sequences can be made by standard procedures and used in the present invention. GDH subunits lacking these targeting sequences are typically found in the cytoplasm of the cell. Such a cytosolic localized enzyme can be useful in capturing ammomum or glutamate compartmentalized in the cytosol of the cell. GDH gene sources. The GDH gene used in the DNA constructs of the present invention can be any GDH gene. It is not limited to the C. sorokiniana GDH genes described above, although they are prefeπed. For example, a GDH gene from bacteria or fungi can be used. The examples provided use the α- andβ-GDH genes of C. sorokiniana, but should not be interpreted in any way to limit the scope of the present invention. Individuals skilled in the art will recognize that various other genes as well as alterations can be made to genes and methods described herein while not departing from the spirit and scope of the present invention. For example, mutagenesis and routine screening can be implemented by techniques well known in the art to produce mutant variants that lack regulation by the cofactor NADPH. Transient expression in maize protoplasts. In order to test the expression of the C. sorokiniana GDH subunits and their assembly into active enzymes in Zea mays cells, vectors were constructed to contain the CaMV E35S promoter, the coding sequence for the mature α-subunit (pMON21904) or β- subunit (pMON21905), the NOS 3 '-untranslated polyadenylation region, and kanamycin resistance for selection in E. coli. The α- and β-subunit genes were isolated as a Xbal- EcoRl fragment from pET lla-α-cDNA and pET lla-β-cDNA respeαively. The GDH genes were ligated into the Xbal-EcόRl E35S promoter, NOS 3', kanamycin resistance bearing region of pMON22072 to give pMON21904, and pMON21905. The DNA constructs were electroporated into maize and wheat protoplast according to the method of Sheen et aL (The Plant Cell Vol. 3, 225-245). Analysis of transformed maize protoplasts. Pelleted protoplast samples transformed with pMON21904 (α-subunit), pMON21905 (β-subunit), pMON21709 (kanamycin negative control DNA), and no DNA were thawed in 0.2 mL of GDH cell breakage buffer (Yeung et aL, supra) on ice. The cells in each suspension were homogenized twice for 30 seconds, chilled on ice, and clarified at 14,000 rpm for 10 minutes. Cell extracts were assayed in the deaminating direαion at 38.5°C according to Yeung et aL, supra. Total protein content of the cell extracts was determined using the BioRad microprotein assay according to the manufacturer's protocol. Activities were normalized against total protein content for comparisons among different preparations. One unit of GDH activity is defined as the amount of enzyme necessary to reduce 1 μmol of NADP per minute at 38.5°C. Protoplasts transformed with the control vector pMON21709 (n=3) or protoplasts not transformed (n=3) had no detectable NADP-GDH activity. Protoplasts transformed with pMON21904 (n=3) expressed 3.31 Units mg ~ l protein of GDH aαivity, whereas pMON21905 transformed protoplasts (n=3) 1.96 Units mg — protein. The high level of activity observed for the protoplasts transformed with the cytoplasmic expressed C sorokiniana α- andβ-NADP-GDH genes provides evidence that the GDH subunits are expressed in heterologous plant systems. Additionally, expression levels demonstrate that the subunits are assembled into active enzymes. Generally, it would be readily apparent to persons of ordinary skill in the art that superfluous sequences added to the described sequences, or fragments of the nucleotide or amino acid sequences described herein, which result in polynucleotides or amino acid sequences that function similarly or equivalently to the sequences expressly described herein, should also be considered part of this invention. They can easily and routinely be produced by techniques well known in the art, for example, by time-controlled Bal31 exonuclease digestion of the full-length DNA followed by expression of the resulting fragments and routine screening of the expression products as described in the foregoing example. In addition, it would be readily accepted by ordinarily skilled artisans that the function, property, or utility of the described sequences can be negatived by inserting mutations into the sequences by standard techniques and procedures. These mutations which, by implication, effectively serve to remove the property or funαion inherent in the sequences as described are hereby expressly included as part of the invention. For example, a clear distinction between the α- and β-subunits of the C. sorokiniana is the 1 l-amino acid polypeptide sequence at the N-terminus of the α- subunit, but absent in the β-subunit. This sequence can affect the affinity, specificity, and modulation of ammonium compounds by the enzyme. Therefore, it would be apparent that inserting (if absent) or removing (if present) the appropriate sequence, or its functional equivalent, to effect a difference in certain charaαeristics of other GDH genes, or their products, would be easily carried out by those persons. It should also be understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art and are to be included within the spirit and purview of this application and the scope of the appended claims. SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT INFORMATION: Applicant Name(s): University of Florida Street Address: 223 Grinter Hall City: Gainesville State/Province: Florida Country: US Postal code/Zip: 32611 Phone number: (352) 392-8929 Fax: (352) 392-6600 (ii) TITLE OF INVENTION: NOVEL POLYPEPTIDES AND POLYNUCLEOTIDES RELATING TO THE α- AND β-SUBUNITS OF GLUTAMATE DΞHYDROGENASES AND METHODS OF USE (iii) NUMBER OF SEQUENCES: 26 (iv) CORRESPONDENCE ADDRESS: (A) ADDRESSEE: Saliwanchik & Saliwanchik (B) STREET: 2421 N.W. 41st Street, Suite A-l (C) CITY: Gainesville (D) STATE: Florida (E) COUNTRY: USA (F) ZIP: 32606 (v) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (0) SOFTWARE: Patentin Release #1.0, Version #1.25 (vi) CURRENT APPLICATION DATA: (A) APPLICATION NUMBER: US (B) FILING DATE: (C) CLASSIFICATION: (viii) ATTORNEY/AGENT INFORMATION: (A) NAME: Whitlock, Ted W. (B) REGISTRATION NUMBER: 36,965 (C) REFERENCE/DOCKET NUMBER: UF155 (ix) TELECOMMUNICATION INFORMATION: (A) TELEPHONE: (904) 375-8100 (B) TELEFAX: (904) 372-5800 (2) INFORMATION FOR SEQ ID NO:l: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2140 baee pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 33..1610 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:l: CTCCTTTCTG CTCGCCCTCT CTCCGTCCCG CC ATG CAG ACC GCC CTC GTC GCC 53 Met Gin Thr Ala Leu Val Ala 1 5 AAG CCT ATC GTG GCC GCC CCG CTG GCG GCA CGC CCG CGC TGC CTC GCG 101 Lys Pro lie Val Ala Ala Pro Leu Ala Ala Arg Pro Arg Cys Leu Ala 10 15 20 CCG TGG CCG TGC GCG TGG GTC CGC TCC GCC AAG CGC GAT GTC CGC GCC 149 Pro Trp Pro Cys Ala Trp Val Arg Ser Ala Lys Arg Asp Val Arg Ala 25 30 35 AAG GCC GTC TCG CTG GAG GAG CAG ATC TCC GCG ATG GAC GCC ACC ACC 197 Lys Ala Val Ser Leu Glu Glu Gin lie Ser Ala Met Asp Ala Thr Thr 40 45 50 55 GGC GAC TTC ACG GCG CTG CAG AAG GCG GTG AAG CAG ATG GCC ACC AAG 245 Gly Aβp Phe Thr Ala Leu Gin Lys Ala Val Lys Gin Met Ala Thr Lys 60 65 70 GCG GGC ACT GAG GGC CTG GTG CAC GGC ATC AAG AAC CCC GAC GTG CGC 293 Ala Gly Thr Glu Gly Leu Val His Gly lie Lys Asn Pro Asp Val Arg 75 80 85 CAG CTG CTG ACC GAG ATC TTC ATG AAG GAC CCG GAG CAG CAG GAG TTC 341 Gin Leu Leu Thr Glu lie Phe Met Lys Aβp Pro Glu Gin Gin Glu Phe 90 95 100 ATG CAG GCG GTG CGC GAG GTG GCC GTC TCC CTG CAG CCC GTG TTC GAG 389 Met Gin Ala Val Arg Glu Val Ala Val Ser Leu Gin Pro Val Phe Glu 105 110 115 AAG CGC CCC GAG CTG CTG CCC ATC TTC AAG CAG ATC GTT GAG CCT GAG 437 Lys Arg Pro Glu Leu Leu Pro lie Phe Lys Gin lie Val Glu Pro Glu 120 125 130 135 CGC GTG ATC ACC TTC CGC GTG TCC TGG CTG GAC GAC GCC GGC AAC CTG 485 Arg Val lie Thr Phe Arg Val Ser Trp Leu Asp Asp Ala Gly Asn Leu 140 145 150 CAG GTC AAC CGC GGC TTC CGC GTG CAG TAC TCG TCC GCC ATC GGC CCC 533 Gin Val Asn Arg Gly Phe Arg Val Gin Tyr Ser Ser Ala He Gly Pro 155 160 165 TAC AAG GGC GGC CTG CGC TTC CAC CCC TCC GTG AAC CTG TCC ATC ATG 581 Tyr Lys Gly Gly Leu Arg Phe His Pro Ser Val Asn Leu Ser He Met 170 175 180 AAG TTC CTT GCC TTT GAG CAG ATC TTC AAG AAC AGC CTG ACC ACC CTG 629 Lys Phe Leu Ala Phe Glu Gin He Phe Lys Asn Ser Leu Thr Thr Leu 185 190 195 CCC ATG GGC GGC GGC AAG GGC GGC TCC GAC TTC GAC CCC AAG GGC AAG 677 Pro Met Gly Gly Gly Lys Gly Gly Ser Aβp Phe Asp Pro Lys Gly Lys 200 205 210 215 AGC GAC GCG GAG GTG ATG CGC TTC TGC CAG TCC TTC ATG ACC GAG CTG 725 Ser Asp Ala Glu Val Met Arg Phe Cys Gin Ser Phe Met Thr Glu Leu 220 225 230 CAG CGC CAC ATC AGC TAC GTG CAG GAC GTG CCC GCC GGC GAC ATC GGC 773 Gin Arg His He Ser Tyr Val Gin Asp Val Pro Ala Gly Asp He Gly 235 240 245 GTG GGC GCG CGC GAG ATT GGC TAC CTT TTC GGC CAG TAC AAG CGC ATC 821 Val Gly Ala Arg Glu He Gly Tyr Leu Phe Gly Gin Tyr Lys Arg He 250 255 260 ACC AAG AAC TAC ACC GGC GTG CTG ACC CCG AAG GGC CAG GAG TAT GGC 869 Thr Lys Asn Tyr Thr Gly Val Leu Thr Pro Lys Gly Gin Glu Tyr Gly 265 270 275 GGC TCC GAG ATC CGC CCC GAG GCC ACC GGC TAC GGC GCC GTG CTG TTT 917 Gly Ser Glu He Arg Pro Glu Ala Thr Gly Tyr Gly Ala Val Leu Phe 280 285 290 295 GTG GAG AAC GTG CTG AAG GAC AAG GGC GAG AGC CTC AAG GGC AAG CGC 965 Val Glu Asn Val Leu Lye Asp Lys Gly Glu Ser Leu Lys Gly Lys Arg 300 305 310 TGC CTG GTG TCT GGC GCG GGC AAC GTG GCC CAG TAC TGC GCG GAG CTG 1013 Cys Leu Val Ser Gly Ala Gly Asn Val Ala Gin Tyr Cys Ala Glu Leu 315 320 325 CTG CTG GAG AAG GGC GCC ATC GTG CTG TCG CTG TCC GAC TCC CAG GGC 1061 Leu Leu Glu Lys Gly Ala He Val Leu Ser Leu Ser Asp Ser Gin Gly 330 335 340 TAC GTG TAC GAG CCC AAC GGC TTC ACG CGC GAG CAG CTG CAG GCG GTG 1109 Tyr Val Tyr Glu Pro Asn Gly Phe Thr Arg Glu Gin Leu Gin Ala Val 345 350 355 CAG GAC ATG AAG AAG AAG AAC AAC AGC GCC CGC ATC TCC GAG TAC AAG 1157 Gin Asp Met Lys Lys Lys Aβn Asn Ser Ala Arg He Ser Glu Tyr Lys 360 365 370 375 AGC GAC ACC GCC GTG TAT GTG GGC GAC CGC CGC AAG CCT TGG GAG CTG 1205 Ser Asp Thr Ala Val Tyr Val Gly Asp Arg Arg Lys Pro Trp Glu Leu 380 385 390 GAC TGC CAG GTG GAC ATC GCC TTC CCC TGC GCC ACC CAG AAC GAG ATC 1253 Asp Cys Gin Val Asp He Ala Phe Pro Cys Ala Thr Gin Asn Glu He 395 400 405 GAT GAG CAC GAC GCC GAG CTG CTG ATC AAG CAC GGC TGC CAG TAC GTG 1301 Aβp Glu His Asp Ala Glu Leu Leu He Lys His Gly Cys Gin Tyr Val 410 415 420 GTG GAG GGC GCC AAC ATG CCC TCC ACC AAC GAG GCC ATC CAC AAG TAC 1349 Val Glu Gly Ala Asn Met Pro Ser Thr Asn Glu Ala He His Lys Tyr 425 430 435 AAC AAG GCC GGC ATC ATC TAC TGC CCC GGC AAG GCG GCC AAC GCC GGC 1397 Aβn Lys Ala Gly He He Tyr Cys Pro Gly Lys Ala Ala Asn Ala Gly 440 445 450 455 GGC GTG GCG GTC AGC GGC CTG GAG ATG ACC CAG AAC CGC ATG AGC CTG 1445 Gly Val Ala Val Ser Gly Leu Glu Met Thr Gin Aβn Arg Met Ser Leu 460 465 470 AAC TGG ACT CGC GAG GAG GTT CGC GAC AAG CTG GAG CGC ATC ATG AAG 1493 Aβn Trp Thr Arg Glu Glu Val Arg Aβp Lye Leu Glu Arg He Met Lye 475 480 485 GAC ATC TAC GAC TCC GCC ATG GGG CCG TCC CGC AGA TAC AAT GTT GAC 1541 Aβp He Tyr Aβp Ser Ala Met Gly Pro Ser Arg Arg Tyr Aβn Val Aβp 490 495 500 CTG GCT GCG GGC GCC AAC ATC GCG GGC TTC ACC AAG GTG GCT GAT GCC 1589 Leu Ala Ala Gly Ala Aβn He Ala Gly Phe Thr Lys Val Ala Asp Ala 505 510 515 GTC AAG GCC CAG GGC GCT GTT TAAGCTGCCC AGGCCCAAGC CACGGCTCAC 1640 Val Lys Ala Gin Gly Ala Val 520 525 CGGCAATCCA ACCCAACCAA CTCAACGGCC AGGACCTTTT CGGAAGCGGC GCCTTTTTCC 1700 CAGCCAGGGC CCTCACCTGC CCTTTCATAA CCCTGCTATT GCCGCCGTGC CCCTGCAATT 1760 CCACCCCAAG AAGAACTAGC GGCACTTGAC TGCATCAGGA CGGCTATTTT TTTCGCGACG 1820 CGCGCTCACC CCGAGAGCCT CTCTCCCCCG AGCCCTAAGC GCTGACGTCC GCCCGACTTT 1880 GCCTCGCACA TCGCTCGGTT TTGACCCCCT CCAGTCTACC CACCCTGTTG TGAAGCCTAC 1940 CAGCTCAATT GCCTTTTAGT GTATGTGCGC CCCCTCCTGC CCCCGAATTT TCCTGCCATG 2000 AGACGTGCGG TTCCTAGCCT GGTGACCCCA AGTAGCAGTT AGTGTGCGTG CCTTGCCCTG 2060 CGCTGCCCGG GATGCGATAC TGTGACCTGA GAGTGCTTGT GTAAACACGA CGAGTCAAAA 2120 AAAAAAAAAA AAAAAAAAAA 2140 (2) INFORMATION FOR SEQ ID NO:2: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 526 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2: Met Gin Thr Ala Leu Val Ala Lye Pro He Val Ala Ala Pro Leu Ala 1 5 10 15 Ala Arg Pro Arg Cyβ Leu Ala Pro Trp Pro Cyβ Ala Trp Val Arg Ser 20 25 30 Ala Lys Arg Asp Val Arg Ala Lys Ala Val Ser Leu Glu Glu Gin He 35 40 45 Ser Ala Met Asp Ala Thr Thr Gly Aβp Phe Thr Ala Leu Gin Lye Ala 50 55 60 Val Lye Gin Met Ala Thr Lye Ala Gly Thr Glu Gly Leu Val Hie Gly 65 70 75 80 He Lys Asn Pro Aβp Val Arg Gin Leu Leu Thr Glu He Phe Met Lys 85 90 95 Aβp Pro Glu Gin Gin Glu Phe Met Gin Ala Val Arg Glu Val Ala Val 100 105 110 Ser Leu Gin Pro Val Phe Glu Lye Arg Pro Glu Leu Leu Pro He Phe 115 120 125 Lye Gin He Val Glu Pro Glu Arg Val He Thr Phe Arg Val Ser Trp 130 135 140 Leu Aβp Asp Ala Gly Asn Leu Gin Val Aβn Arg Gly Phe Arg Val Gin 145 150 155 160 Tyr Ser Ser Ala He Gly Pro Tyr Lye Gly Gly Leu Arg Phe Hie Pro 165 170 175 Ser Val Aβn Leu Ser He Met Lye Phe Leu Ala Phe Glu Gin He Phe 180 185 190 Lye Aβn Ser Leu Thr Thr Leu Pro Met Gly Gly Gly Lye Gly Gly Ser 195 200 205 Aβp Phe Aβp Pro Lye Gly Lys Ser Asp Ala Glu Val Met Arg Phe Cyβ 210 215 220 Gin Ser Phe Met Thr Glu Leu Gin Arg Hie He Ser Tyr Val Gin Asp 225 230 235 240 Val Pro Ala Gly Aβp He Gly Val Gly Ala Arg Glu He Gly Tyr Leu 245 250 255 Phe Gly Gin Tyr Lys Arg He Thr Lys Asn Tyr Thr Gly Val Leu Thr 260 265 270 Pro Lys Gly Gin Glu Tyr Gly Gly Ser Glu He Arg Pro Glu Ala Thr 275 280 285 Gly Tyr Gly Ala Val Leu Phe Val Glu Asn Val Leu Lys Asp Lys Gly 290 295 300 Glu Ser Leu Lys Gly Lye Arg Cys Leu Val Ser Gly Ala Gly Asn Val 305 310 315 320 Ala Gin Tyr Cyβ Ala Glu Leu Leu Leu Glu Lye Gly Ala He Val Leu 325 330 335 Ser Leu Ser Aβp Ser Gin Gly Tyr Val Tyr Glu Pro Asn Gly Phe Thr 340 345 350 Arg Glu Gin Leu Gin Ala Val Gin Aβp Met Lye Lys Lys Asn Asn Ser 355 360 365 Ala Arg He Ser Glu Tyr Lys Ser Aβp Thr Ala Val Tyr Val Gly Aβp 370 375 380 Arg Arg Lye Pro Trp Glu Leu Aep Cyβ Gin Val Aβp He Ala Phe Pro 385 390 395 400 Cyβ Ala Thr Gin Aβn Glu He Aβp Glu Hie Aβp Ala Glu Leu Leu He 405 410 415 Lys His Gly Cys Gin Tyr Val Val Glu Gly Ala Asn Met Pro Ser Thr 420 425 430 Asn Glu Ala He His Lys Tyr Asn Lys Ala Gly He He Tyr Cys Pro 435 440 445 Gly Lys Ala Ala Asn Ala Gly Gly Val Ala Val Ser Gly Leu Glu Met 450 455 460 Thr Gin Asn Arg Met Ser Leu Aβn Trp Thr Arg Glu Glu Val Arg Aβp 465 470 475 480 Lye Leu Glu Arg He Met Lye Asp He Tyr Asp Ser Ala Met Gly Pro 485 490 495 Ser Arg Arg Tyr Asn Val Asp Leu Ala Ala Gly Ala Asn He Ala Gly 500 505 510 Phe Thr Lys Val Ala Asp Ala Val Lys Ala Gin Gly Ala Val 515 520 525 (2) INFORMATION FOR SEQ ID NO:3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2099 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 33..1568 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3: CTCCTTTCTG CTCGCCCTCT CTCCGTCCCG CC ATG CAG ACC GCC CTC GTC GCC 53 Met Gin Thr Ala Leu Val Ala 1 5 AAG CCT ATC GTG GCC TGC GCG TGG GTC CGC TCC GCC AAG CGC GAT GTC 101 Lys Pro He Val Ala Cys Ala Trp Val Arg Ser Ala Lys Arg Asp Val 10 15 20 CGC GCC AAG GCC GTC TCG CTG GAG GAG CAG ATC TCC GCG ATG GAC GCC 149 Arg Ala Lye Ala Val Ser Leu Glu Glu Gin He Ser Ala Met Aβp Ala 25 30 35 ACC ACC GGC GAC TTC ACG GCG CTG CAG AAG GCG GTG AAG CAG ATG GCC 197 Thr Thr Gly Aβp Phe Thr Ala Leu Gin Lye Ala Val Lye Gin Met Ala 40 45 50 55 ACC AAG GCG GGC ACT GAG GGC CTG GTG CAC GGC ATC AAG AAC CCC GAC 245 Thr Lye Ala Gly Thr Glu Gly Leu Val Hie Gly He Lye Asn Pro Aβp 60 65 70 GTG CGC CAG CTG CTG ACC GAG ATC TTC ATG AAG GAC CCG GAG CAG CAG 293 Val Arg Gin Leu Leu Thr Glu He Phe Met Lys Aβp Pro Glu Gin Gin 75 80 85 GAG TTC ATG CAG GCG GTG CGC GAG GTG GCC GTC TCC CTG CAG CCC GTG 341 Glu Phe Met Gin Ala Val Arg Glu Val Ala Val Ser Leu Gin Pro Val 90 95 100 TTC GAG AAG CGC CCC GAG CTG CTG CCC ATC TTC AAG CAG ATC GTT GAG 389 Phe Glu Lys Arg Pro Glu Leu Leu Pro He Phe Lye Gin He Val Glu 105 110 115 CCT GAG CGC GTG ATC ACC TTC CGC GTG TCC TGG CTG GAC GAC GCC GGC 437 Pro Glu Arg Val He Thr Phe Arg Val Ser Trp Leu Aβp Aβp Ala Gly 120 125 130 135 AAC CTG CAG GTC AAC CGC GGC TTC CGC GTG CAG TAC TCG TCC GCC ATC 485 Aβn Leu Gin Val Aβn Arg Gly Phe Arg Val Gin Tyr Ser Ser Ala He 140 145 150 GGC CCC TAC AAG GGC GGC CTG CGC TTC CAC CCC TCC GTG AAC CTG TCC 533 Gly Pro Tyr Lye Gly Gly Leu Arg Phe Hie Pro Ser Val Aβn Leu Ser 155 160 165 ATC ATG AAG TTC CTT GCC TTT GAG CAG ATC TTC AAG AAC AGC CTG ACC 581 He Met Lye Phe Leu Ala Phe Glu Gin He Phe Lys Aβn Ser Leu Thr 170 175 180 ACC CTG CCC ATG GGC GGC GGC AAG GGC GGC TCC GAC TTC GAC CCC AAG 629 Thr Leu Pro Met Gly Gly Gly Lys Gly Gly Ser Asp Phe Asp Pro Lys 185 190 195 GGC AAG AGC GAC GCG GAG GTG ATG CGC TTC TGC CAG TCC TTC ATG ACC 677 Gly Lye Ser Asp Ala Glu Val Met Arg Phe Cys Gin Ser Phe Met Thr 200 205 210 215 GAG CTG CAG CGC CAC ATC AGC TAC GTG CAG GAC GTG CCC GCC GGC GAC 725 Glu Leu Gin Arg His He Ser Tyr Val Gin Asp Val Pro Ala Gly Asp 220 225 230 ATC GGC GTG GGC GCG CGC GAG ATT GGC TAC CTT TTC GGC CAG TAC AAG 773 He Gly Val Gly Ala Arg Glu He Gly Tyr Leu Phe Gly Gin Tyr Lys 235 240 245 CGC ATC ACC AAG AAC TAC ACC GGC GTG CTG ACC CCG AAG GGC CAG GAG 821 Arg He Thr Lys Asn Tyr Thr Gly Val Leu Thr Pro Lys Gly Gin Glu 250 255 260 TAT GGC GGC TCC GAG ATC CGC CCC GAG GCC ACC GGC TAC GGC GCC GTG 869 Tyr Gly Gly Ser Glu He Arg Pro Glu Ala Thr Gly Tyr Gly Ala Val 265 270 275 CTG TTT GTG GAG AAC GTG CTG AAG GAC AAG GGC GAG AGC CTC AAG GGC 917 Leu Phe Val Glu Asn Val Leu Lys Asp Lys Gly Glu Ser Leu Lys Gly 280 285 290 295 AAG CGC TGC CTG GTG TCT GGC GCG GGC AAC GTG GCC CAG TAC TGC GCG 965 Lys Arg Cys Leu Val Ser Gly Ala Gly Asn Val Ala Gin Tyr Cys Ala 300 305 310 GAG CTG CTG CTG GAG AAG GGC GCC ATC GTG CTG TCG CTG TCC GAC TCC 1013 Glu Leu Leu Leu Glu Lys Gly Ala He Val Leu Ser Leu Ser Asp Ser 315 320 325 CAG GGC TAC GTG TAC GAG CCC AAC GGC TTC ACG CGC GAG CAG CTG CAG 1061 Gin Gly Tyr Val Tyr Glu Pro Asn Gly Phe Thr Arg Glu Gin Leu Gin 330 335 340 GCG GTG CAG GAC ATG AAG AAG AAG AAC AAC AGC GCC CGC ATC TCC GAG 1109 Ala Val Gin Asp Met Lys Lys Lye Aβn Aβn Ser Ala Arg He Ser Glu 345 350 355 TAC AAG AGC GAC ACC GCC GTG TAT GTG GGC GAC CGC CGC AAG CCT TGG 1157 Tyr Lys Ser Asp Thr Ala Val Tyr Val Gly Aβp Arg Arg Lys Pro Trp 360 365 370 375 GAG CTG GAC TGC CAG GTG GAC ATC GCC TTC CCC TGC GCC ACC CAG AAC 1205 Glu Leu Aβp Cyβ Gin Val Aep He Ala Phe Pro Cyβ Ala Thr Gin Aβn 380 385 390 GAG ATC GAT GAG CAC GAC GCC GAG CTG CTG ATC AAG CAC GGC TGC CAG 1253 Glu He Asp Glu His Asp Ala Glu Leu Leu He Lys His Gly Cys Gin 395 400 405 TAC GTG GTG GAG GGC GCC AAC ATG CCC TCC ACC AAC GAG GCC ATC CAC 1301 Tyr Val Val Glu Gly Ala Aβn Met Pro Ser Thr Aβn Glu Ala He His 410 415 420 AAG TAC AAC AAG GCC GGC ATC ATC TAC TGC CCC GGC AAG GCG GCC AAC 1349 Lye Tyr Asn Lye Ala Gly He He Tyr Cyβ Pro Gly Lye Ala Ala Aβn 425 430 435 GCC GGC GGC GTG GCG GTC AGC GGC CTG GAG ATG ACC CAG AAC CGC ATG 1397 Ala Gly Gly Val Ala Val Ser Gly Leu Glu Met Thr Gin Aβn Arg Met 440 445 450 455 AGC CTG AAC TGG ACT CGC GAG GAG GTT CGC GAC AAG CTG GAG CGC ATC 1445 Ser Leu Aβn Trp Thr Arg Glu Glu Val Arg Aβp Lye Leu Glu Arg He 460 465 470 ATG AAG GAC ATC TAC GAC TCC GCC ATG GGG CCG TCC CGC AGA TAC AAT 1493 Met Lys Aep He Tyr Aβp Ser Ala Met Gly Pro Ser Arg Arg Tyr Asn 475 480 485 GTT GAC CTG GCT GCG GGC GCC AAC ATC GCG GGC TTC ACC AAG GTG GCT 1541 Val Asp Leu Ala Ala Gly Ala Aβn He Ala Gly Phe Thr Lye Val Ala 490 495 500 GAT GCC GTC AAG GCC CAG GGC GCT GTT TAAGCTGCCC AGGCCCAAGC 1588 Aβp Ala Val Lye Ala Gin Gly Ala Val 505 510 CACGGCTCAC CGGCAATCCA ACCCAACCAA CTCAACGGCC AGGACCTTTT CGGAAGCGGC 1648 GCCTTTTTCC CAGCCAGGGC CCTCACCTGC CCTTTCATAA CCCTGCTATT GCCGCCGTGC 1708 CCCTGCAATT CCACCCCAAG AAGAACTAGC GGCACTTGAC TGCATCAGGA CGGCTATTTT 1768 TTTCGCGACG CGCGCTCACC CCGAGAGCCT CTCTCCCCCG AGCCCTAAGC GCTGACGTCC 1828 GCCCGACTTT GCCTCGCACA TCGCTCGGTT TTGACCCCCT CCAGTCTACC CACCCTGTTG 1888 TGAAGCCTAC CAGCTCAATT GCCTTTTAGT GTATGTGCGC CCCCTCCTGC CCCCGAATTT 1948 TCCTGCCATG AGACGTGCGG TTCCTAGCCT GGTGACCCCA AGTAGCAGTT AGTGTGCGTG 2008 CCTTGCCCTG CGCTGCCCGG GATGCGATAC TGTGACCTGA GAGTGCTTGT GTAAACACGA 2068 CGAGTCAAAA AAAAAAAAAA AAAAAAAAAA A 2099 (2) INFORMATION FOR SEQ ID NO:4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 512 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4: Met Gin Thr Ala Leu Val Ala Lye Pro He Val Ala Cyβ Ala Trp Val 1 5 10 15 Arg Ser Ala Lye Arg Asp Val Arg Ala Lys Ala Val ser Leu Glu Glu 20 25 30 Gin He Ser Ala Met Asp Ala Thr Thr Gly Aβp Phe Thr Ala Leu Gin 35 40 45 Lys Ala Val Lys Gin Met Ala Thr Lys Ala Gly Thr Glu Gly Leu Val 50 55 60 His Gly He Lys Asn Pro Asp Val Arg Gin Leu Leu Thr Glu He Phe 65 70 75 80 Met Lys Asp Pro Glu Gin Gin Glu Phe Met Gin Ala Val Arg Glu Val 85 90 95 Ala Val Ser Leu Gin Pro Val Phe Glu Lye Arg Pro Glu Leu Leu Pro 100 105 110 He Phe Lye Gin He Val Glu Pro Glu Arg Val He Thr Phe Arg Val 115 120 125 Ser Trp Leu Aβp Aβp Ala Gly Aβn Leu Gin Val Aβn Arg Gly Phe Arg 130 135 140 Val Gin Tyr Ser Ser Ala He Gly Pro Tyr Lye Gly Gly Leu Arg Phe 145 150 155 160 Hie Pro Ser Val Aβn Leu Ser He Met Lye Phe Leu Ala Phe Glu Gin 165 170 175 He Phe Lye Aβn Ser Leu Thr Thr Leu Pro Met Gly Gly Gly Lye Gly 180 185 190 Gly Ser Aβp Phe Aβp Pro Lye Gly Lye Ser Aβp Ala Glu Val Met Arg 195 200 205 Phe Cyβ Gin Ser Phe Met Thr Glu Leu Gin Arg His He Ser Tyr Val 210 215 220 Gin Aβp Val Pro Ala Gly Aβp He Gly Val Gly Ala Arg Glu He Gly 225 230 235 240 Tyr Leu Phe Gly Gin Tyr Lye Arg He Thr Lye Aβn Tyr Thr Gly Val 245 250 255 Leu Thr Pro Lye Gly Gin Glu Tyr Gly Gly Ser Glu He Arg Pro Glu 260 265 270 Ala Thr Gly Tyr Gly Ala Val Leu Phe Val Glu Asn Val Leu Lye Aβp 275 280 285 Lye Gly Glu Ser Leu Lye Gly Lys Arg Cys Leu Val Ser Gly Ala Gly 290 295 300 Aβn Val Ala Gin Tyr Cyβ Ala Glu Leu Leu Leu Glu Lys Gly Ala He 305 310 315 320 Val Leu Ser Leu Ser Aβp Ser Gin Gly Tyr Val Tyr Glu Pro Aβn Gly 325 330 335 Phe Thr Arg Glu Gin Leu Gin Ala Val Gin Asp Met Lye Lye Lye Aβn 340 345 350 Aβn Ser Ala Arg He Ser Glu Tyr Lye Ser Aβp Thr Ala Val Tyr Val 355 360 365 Gly Aβp Arg Arg Lye Pro Trp Glu Leu Aep Cyβ Gin Val Aβp He Ala 370 375 380 Phe Pro Cyβ Ala Thr Gin Aβn Glu He Aβp Glu His Aβp Ala Glu Leu 385 390 395 400 Leu He Lys Hie Gly Cys Gin Tyr Val Val Glu Gly Ala Asn Met Pro 405 410 415 Ser Thr Aβn Glu Ala He His Lye Tyr Aβn Lye Ala Gly He He Tyr 420 425 430 Cyβ Pro Gly Lye Ala Ala Aβn Ala Gly Gly Val Ala Val Ser Gly Leu 435 440 445 Glu Met Thr Gin Aβn Arg Met Ser Leu Asn Trp Thr Arg Glu Glu Val 450 455 460 Arg Asp Lys Leu Glu Arg He Met Lys Aβp He Tyr Asp Ser Ala Met 465 470 475 480 Gly Pro Ser Arg Arg Tyr Asn Val Aβp Leu Ala Ala Gly Ala Aβn He 485 490 495 Ala Gly Phe Thr Lys Val Ala Aβp Ala Val Lye Ala Gin Gly Ala Val 500 505 510 (2) INFORMATION FOR SEQ ID NO:5: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 amino acide (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5: Ala Val Ser Leu Glu Glu Gin He Ser Ala Met Asp Ala Thr Thr Gly 1 5 10 15 Asp Phe Thr Ala 20 (2) INFORMATION FOR SEQ ID NO:6: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 10 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6: Asp Ala Thr Thr Gly Asp Phe Thr Ala Leu 1 5 10 (2) INFORMATION FOR SEQ ID NO:7: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1969 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7: CAGATCTCCG CGATGGACGC CACCACCGGC GACTTCACGG CGCTGCAGAA GGCGGTGAAG 60 CAGATGGCCA CCAAGGCGGG CACTGAGGGC CTGGTGCACG GCATCAAGAA CCCCGACGTG 120 CGCCAGCTGC TGACCGAGAT CTTCATGAAG GACCCGGAGC AGCAGGAGTT CATGCAGGCG 180 GTGCGCGAGG TGGCCGTCTC CCTGCAGCCC GTGTTCGAGA AGCGCCCCGA GCTGCTGCCC 240 ATCTTCAAGC AGATCGTTGA GCCTGAGCGC GTGATCACCT TCCGCGTGTC CTGGCTGGAC 300 GACGCCGGCA ACCTGCAGGT CAACCGCGGC TTCCGCGTGC AGTACTCGTC CGCCATCGGC 360 CCCTACAAGG GCGGCCTGCG CTTCCACCCC TCCGTGAACC TGTCCATCAT GAAGTTCCTT 420 GCCTTTGAGC AGATCTTCAA GAACAGCCTG ACCACCCTGC CCATGGGCGG CGGCAAGGGC 480 GGCTCCGACT TCGACCCCAA GGGCAAGAGC GACGCGGAGG TGATGCGCTT CTGCCAGTCC 540 TTCATGACCG AGCTGCAGCG CCACATCAGC TACGTGCAGG ACGTGCCCGC CGGCGACATC 600 GGCGTGGGCG CGCGCGAGAT TGGCTACCTT TTCGGCCAGT ACAAGCGCAT CACCAAGAAC 660 TACACCGGCG TGCTGACCCC GAAGGGCCAG GAGTATGGCG GCTCCGAGAT CCGCCCCGAG 720 GCCACCGGCT ACGGCGCCGT GCTGTTTGTG GAGAACGTGC TGAAGGACAA GGGCGAGAGC 780 CTCAAGGGCA AGCGCTGCCT GGTGTCTGGC GCGGGCAACG TGGCCCAGTA CTGCGCGGAG 840 CTGCTGCTGG AGAAGGGCGC CATCGTGCTG TCGCTGTCCG ACTCCCAGGG CTACGTGTAC 900 GAGCCCAACG GCTTCACGCG CGAGCAGCTG CAGGCGGTGC AGGACATGAA GAAGAAGAAC 960 AACAGCGCCC GCATCTCCGA GTACAAGAGC GACACCGCCG TGTATGTGGG CGACCGCCGC 1020 AAGCCTTGGG AGCTGGACTG CCAGGTGGAC ATCGCCTTCC CCTGCGCCAC CCAGAACGAG 1080 ATCGATGAGC ACGACGCCGA GCTGCTGATC AAGCACGGCT GCCAGTACGT GGTGGAGGGC 1140 GCCAACATGC CCTCCACCAA CGAGGCCATC CACAAGTACA ACAAGGCCGG CATCATCTAC 1200 TGCCCCGGCA AGGCGGCCAA CGCCGGCGGC GTGGCGGTCA GCGGCCTGGA GATGACCCAG 1260 AACCGCATGA GCCTGAACTG GACTCGCGAG GAGGTTCGCG ACAAGCTGGA GCGCATCATG 1320 AAGGACATCT ACGACTCCGC CATGGGGCCG TCCCGCAGAT ACAATGTTGA CCTGGCTGCG 1380 GGCGCCAACA TCGCGGGCTT CACCAAGGTG GCTGATGCCG TCAAGGCCCA GGGCGCTGTT 1440 TAAGCTGCCC AGGCCCAAGC CACGGCTCAC CGGCAATCCA ACCCAACCAA CTCAACGGCC 1500 AGGACCTTTT CGGAAGCGGC GCCTTTTTCC CAGCCAGGGC CCTCACCTGC CCTTTCATAA 1560 CCCTGCTATT GCCGCCGTGC CCCTGCAATT CCACCCCAAG AAGAACTAGC GGCACTTGAC 1620 TGCATCAGGA CGGCTATTTT TTTCGCGACG CGCGCTCACC CCGAGAGCCT CTCTCCCCCG 1680 AGCCCTAAGC GCTGACGTCC GCCCGACTTT GCCTCGCACA TCGCTCGGTT TTGACCCCCT 1740 CCAGTCTACC CACCCTGTTG TGAAGCCTAC CAGCTCAATT GCCTTTTAGT GTATGTGCGC 1800 CCCCTCCTGC CCCCGAATTT TCCTGCCATG AGACGTGCGG TTCCTAGCCT GGTGACCCCA 1860 AGTAGCAGTT AGTGTGCGTG CCTTGCCCTG CGCTGCCCGG GATGCGATAC TGTGACCTGA 1920 GAGTGCTTGT GTAAACACGA CGAGTCAAAA AAAAAAAAAA AAAAAAAAA 1969 (2) INFORMATION FOR SEQ ID NO:8: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 22 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8: CTCAAAGGCA AGGAACTTCA TG 22 (2) INFORMATION FOR SEQ ID NO:9: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 50 base pairβ (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: CDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9: GGGTCGACAT TCTAGACAGA ATTCGTGGAT CCTTTTTTTT TTTTTTTTTT 50 (2) INFORMATION FOR SEQ ID NO:10: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:10: GGACGAGTAC TGCACGC 17 (2) INFORMATION FOR SEQ ID NO:11: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 18 base pairβ (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: CDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:ll: GATCTCGGTC AGCAGCTG 18 (2) INFORMATION FOR SEQ ID NO:12: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairβ (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: CDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:12: GGGTCGACAT TCTAGACAGA A 21 (2) INFORMATION FOR SEQ ID NO:13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 367 base paire (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: CDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:13: GGGTCGACAT TCTAGACAGA ATTCGTGGAT CCTTTTTTTT TTTTTTTTTT TTTTTTCTCC 60 TTTCTGCTCG CCCTCTCTCC GTCCCGCCAT GCAGACCGCC CTCGTCGCCA AGCCTATCGT 120 GGCCGCCCCG CTGGCGGCAC GCCCGCGCTG CCTCGCGCCG TGGCCGTGCG CGTGGGTCCG 180 CTCCGCCAAG CGCGATGTCC GCGCCAAGGC CGTCTCGCTG GAGGAGCAGA TCTCCGCGAT 240 GGACGCCACC ACCGGCGACT TCACGGCGCT GCAGAAGGCG GTGAAGCAGA TGGCCACCAA 300 GGCGGGCACT GAGGGCCTGG TGCACGGCAT CAAGAACCCC GACGTGCGCC AGCTGCTGAC 360 CGAGATC 367 (2) INFORMATION FOR SEQ ID NO:14: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 325 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: CDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:14: GGGTCGACAT TCTAGACAGA ATTCGTGGAT CCTTTTTTTT TTTTTTTTTT TTTTTTCTCC 60 TTTCTGCTCG CCCTCTCTCC GTCCCGCCAT GCAGACCGCC CTCGTCGCCA AGCCTATCGT 120 GGCCTGCGCG TGGGTCCGCT CCGCCAAGCG CGATGTCCGC GCCAAGGCCG TCTCGCTGGA 180 GGAGCAGATC TCCGCGATGG ACGCCACCAC CGGCGACTTC ACGGCGCTGC AGAAGGCGGT 240 GAAGCAGATG GCCACCAAGG CGGGCACTGA GGGCCTGGTG CACGGCATCA AGAACCCCGA 300 CGTGCGCCAG CTGCTGACCG AGATC 325 (2) INFORMATION FOR SEQ ID NO:15: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 18 base pairβ (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: CDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:15: CTTTCTGCTC GCCCTCTC 18 (2) INFORMATION FOR SEQ ID NO:16: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 308 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: CDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:16: CTTTCTGCTC GCCCTCTCTC CGTCCCGCCA TGCAGACCGC CCTCGTCGCC AAGCCTATCG 60 TGGCCGCCCC GCTGGCGGCA CGCCCGCGCT GCCTCGCGCC GTGGCCGTGC GCGTGGGTCC 120 GCTCCGCCAA GCGCGATGTC CGCGCCAAGG CCGTCTCGCT GGAGGAGCAG ATCTCCGCGA 180 TGGACGCCAC CACCGGCGAC TTCACGGCGC TGCAGAAGGC GGTGAAGCAG ATGGCCACCA 240 AGGCGGGCAC TGAGGGCCTG GTGCACGGCA TCAAGAACCC CGACGTGCGC CAGCTGCTGA 300 CCGAGATC 308 (2) INFORMATION FOR SEQ ID NO:17: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 266 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: CDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:17: CTTTCTGCTC GCCCTCTCTC CGTCCCGCCA TGCAGACCGC CCTCGTCGCC AAGCCTATCG 60 TGGCCTGCGC GTGGGTCCGC TCCGCCAAGC GCGATGTCCG CGCCAAGGCC GTCTCGCTGG 120 AGGAGCAGAT CTCCGCGATG GACGCCACCA CCGGCGACTT CACGGCGCTG CAGAAGGCGG 180 TGAAGCAGAT GGCCACCAAG GCGGGCACTG AGGGCCTGGT GCACGGCATC AAGAACCCCG 240 ACGTGCGCCA GCTGCTGACC GAGATC 266 (2) INFORMATION FOR SEQ ID NO:18: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2137 base pairβ (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: CDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:18: CTTTCTGCTC GCCCTCTCTC CGTCCCGCCA TGCAGACCGC CCTCGTCGCC AAGCCTATCG 60 TGGCCGCCCC GCTGGCGGCA CGCCCGCGCT GCCTCGCGCC GTGGCCGTGC GCGTGGGTCC 120 GCTCCGCCAA GCGCGATGTC CGCGCCAAGG CCGTCTCGCT GGAGGAGCAG ATCTCCGCGA 180 TGGACGCCAC CACCGGCGAC TTCACGGCGC TGCAGAAGGC GGTGAAGCAG ATGGCCACCA 240 AGGCGGGCAC TGAGGGCCTG GTGCACGGCA TCAAGAACCC CGACGTGCGC CAGCTGCTGA 300 CCGAGATCTT CATGAAGGAC CCGGAGCAGC AGGAGTTCAT GCAGGCGGTG CGCGAGGTGG 360 CCGTCTCCCT GCAGCCCGTG TTCGAGAAGC GCCCCGAGCT GCTGCCCATC TTCAAGCAGA 420 TCGTTGAGCC TGAGCGCGTG ATCACCTTCC GCGTGTCCTG GCTGGACGAC GCCGGCAACC 480 TGCAGGTCAA CCGCGGCTTC CGCGTGCAGT ACTCGTCCGC CATCGGCCCC TACAAGGGCG 540 GCCTGCGCTT CCACCCCTCC GTGAACCTGT CCATCATGAA GTTCCTTGCC TTTGAGCAGA 600 TCTTCAAGAA CAGCCTGACC ACCCTGCCCA TGGGCGGCGG CAAGGGCGGC TCCGACTTCG 660 ACCCCAAGGG CAAGAGCGAC GCGGAGGTGA TGCGCTTCTG CCAGTCCTTC ATGACCGAGC 720 TGCAGCGCCA CATCAGCTAC GTGCAGGACG TGCCCGCCGG CGACATCGGC GTGGGCGCGC 780 GCGAGATTGG CTACCTTTTC GGCCAGTACA AGCGCATCAC CAAGAACTAC ACCGGCGTGC 840 TGACCCCGAA GGGCCAGGAG TATGGCGGCT CCGAGATCCG CCCCGAGGCC ACCGGCTACG 900 GCGCCGTGCT GTTTGTGGAG AACGTGCTGA AGGACAAGGG CGAGAGCCTC AAGGGCAAGC 960 GCTGCCTGGT GTCTGGCGCG GGCAACGTGG CCCAGTACTG CGCGGAGCTG CTGCTGGAGA 1020 AGGGCGCCAT CGTGCTGTCG CTGTCCGACT CCCAGGGCTA CGTGTACGAG CCCAACGGCT 1080 TCACGCGCGA GCAGCTGCAG GCGGTGCAGG ACATGAAGAA GAAGAACAAC AGCGCCCGCA 1140 TCTCCGAGTA CAAGAGCGAC ACCGCCGTGT ATGTGGGCGA CCGCCGCAAG CCTTGGGAGC 1200 TGGACTGCCA GGTGGACATC GCCTTCCCCT GCGCCACCCA GAACGAGATC GATGAGCACG 1260 ACGCCGAGCT GCTGATCAAG CACGGCTGCC AGTACGTGGT GGAGGGCGCC AACATGCCCT 1320 CCACCAACGA GGCCATCCAC AAGTACAACA AGGCCGGCAT CATCTACTGC CCCGGCAAGG 1380 CGGCCAACGC CGGCGGCGTG GCGGTCAGCG GCCTGGAGAT GACCCAGAAC CGCATGAGCC 1440 TGAACTGGAC TCGCGAGGAG GTTCGCGACA AGCTGGAGCG CATCATGAAG GACATCTACG 1500 ACTCCGCCAT GGGGCCGTCC CGCAGATACA ATGTTGACCT GGCTGCGGGC GCCAACATCG 1560 CGGGCTTCAC CAAGGTGGCT GATGCCGTCA AGGCCCAGGG CGCTGTTTAA GCTGCCCAGG 1620 CCCAAGCCAC GGCTCACCGG CAATCCAACC CAACCAACTC AACGGCCAGG ACCTTTTCGG 1680 AAGCGGCGCC TTTTTCCCAG CCAGGGCCCT CACCTGCCCT TTCATAACCC TGCTATTGCC 1740 GCCGTGCCCC TGCAATTCCA CCCCAAGAAG AACTAGCGGC ACTTGACTGC ATCAGGACGG 1800 CTATTTTTTT CGCGACGCGC GCTCACCCCG AGAGCCTCTC TCCCCCGAGC CCTAAGCGCT 1860 GACGTCCGCC CGACTTTGCC TCGCACATCG CTCGGTTTTG ACCCCCTCCA GTCTACCCAC 1920 CCTGTTGTGA AGCCTACCAG CTCAATTGCC TTTTAGTGTA TGTGCGCCCC CTCCTGCCCC 1980 CGAATTTTCC TGCCATGAGA CGTGCGGTTC CTAGCCTGGT GACCCCAAGT AGCAGTTAGT 2040 GTGCGTGCCT TGCCCTGCGC TGCCCGGGAT GCGATACTGT GACCTGAGAG TGCTTGTGTA 2100 AACACGACGA GTCAAAAAAA AAAAAAAAAA AAAAAAA 2137 (2) INFORMATION FOR SEQ ID NO:19: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2096 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: CDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:19: CTTTCTGCTC GCCCTCTCTC CGTCCCGCCA TGCAGACCGC CCTCGTCGCC AAGCCTATCG 60 TGGCCTGCGC GTGGGTCCGC TCCGCCAAGC GCGATGTCCG CGCCAAGGCC GTCTCGCTGG 120 AGGAGCAGAT CTCCGCGATG GACGCCACCA CCGGCGACTT CACGGCGCTG CAGAAGGCGG 180 TGAAGCAGAT GGCCACCAAG GCGGGCACTG AGGGCCTGGT GCACGGCATC AAGAACCCCG 240 ACGTGCGCCA GCTGCTGACC GAGATCTTCA TGAAGGACCC GGAGCAGCAG GAGTTCATGC 300 AGGCGGTGCG CGAGGTGGCC GTCTCCCTGC AGCCCGTGTT CGAGAAGCGC CCCGAGCTGC 360 TGCCCATCTT CAAGCAGATC GTTGAGCCTG AGCGCGTGAT CACCTTCCGC GTGTCCTGGC 420 TGGACGACGC CGGCAACCTG CAGGTCAACC GCGGCTTCCG CGTGCAGTAC TCGTCCGCCA 480 TCGGCCCCTA CAAGGGCGGC CTGCGCTTCC ACCCCTCCGT GAACCTGTCC ATCATGAAGT 540 TCCTTGCCTT TGAGCAGATC TTCAAGAACA GCCTGACCAC CCTGCCCATG GGCGGCGGCA 600 AGGGCGGCTC CGACTTCGAC CCCAAGGGCA AGAGCGACGC GGAGGTGATG CGCTTCTGCC 660 AGTCCTTCAT GACCGAGCTG CAGCGCCACA TCAGCTACGT GCAGGACGTG CCCGCCGGCG 720 ACATCGGCGT GGGCGCGCGC GAGATTGGCT ACCTTTTCGG CCAGTACAAG CGCATCACCA 780 AGAACTACAC CGGCGTGCTG ACCCCGAAGG GCCAGGAGTA TGGCGGCTCC GAGATCCGCC 840 CCGAGGCCAC CGGCTACGGC GCCGTGCTGT TTGTGGAGAA CGTGCTGAAG GACAAGGGCG 900 AGAGCCTCAA GGGCAAGCGC TGCCTGGTGT CTGGCGCGGG CAACGTGGCC CAGTACTGCG 960 CGGAGCTGCT GCTGGAGAAG GGCGCCATCG TGCTGTCGCT GTCCGACTCC CAGGGCTACG 1020 TGTACGAGCC CAACGGCTTC ACGCGCGAGC AGCTGCAGGC GGTGCAGGAC ATGAAGAAGA 1080 AGAACAACAG CGCCCGCATC TCCGAGTACA AGAGCGACAC CGCCGTGTAT GTGGGCGACC 1140 GCCGCAAGCC TTGGGAGCTG GACTGCCAGG TGGACATCGC CTTCCCCTGC GCCACCCAGA 1200 ACGAGATCGA TGAGCACGAC GCCGAGCTGC TGATCAAGCA CGGCTGCCAG TACGTGGTGG 1260 AGGGCGCCAA CATGCCCTCC ACCAACGAGG CCATCCACAA GTACAACAAG GCCGGCATCA 1320 TCTACTGCCC CGGCAAGGCG GCCAACGCCG GCGGCGTGGC GGTCAGCGGC CTGGAGATGA 1380 CCCAGAACCG CATGAGCCTG AACTGGACTC GCGAGGAGGT TCGCGACAAG CTGGAGCGCA 1440 TCATGAAGGA CATCTACGAC TCCGCCATGG GGCCGTCCCG CAGATACAAT GTTGACCTGG 1500 CTGCGGGCGC CAACATCGCG GGCTTCACCA AGGTGGCTGA TGCCGTCAAG GCCCAGGGCG 1560 CTGTTTAAGC TGCCCAGGCC CAAGCCACGG CTCACCGGCA ATCCAACCCA ACCAACTCAA 1620 CGGCCAGGAC CTTTTCGGAA GCGGCGCCTT TTTCCCAGCC AGGGCCCTCA CCTGCCCTTT 1680 CATAACCCTG CTATTGCCGC CGTGCCCCTG CAATTCCACC CCAAGAAGAA CTAGCGGCAC 1740 TTGACTGCAT CAGGACGGCT ATTTTTTTCG CGACGCGCGC TCACCCCGAG AGCCTCTCTC 1800 CCCCGAGCCC TAAGCGCTGA CGTCCGCCCG ACTTTGCCTC GCACATCGCT CGGTTTTGAC 1860 CCCCTCCAGT CTACCCACCC TGTTGTGAAG CCTACCAGCT CAATTGCCTT TTAGTGTATG 1920 TGCGCCCCCT CCTGCCCCCG AATTTTCCTG CCATGAGACG TGCGGTTCCT AGCCTGGTGA 1980 CCCCAAGTAG CAGTTAGTGT GCGTGCCTTG CCCTGCGCTG CCCGGGATGC GATACTGTGA 2040 CCTGAGAGTG CTTGTGTAAA CACGACGAGT CAAAAAAAAA AAAAAAAAAA AAAAAA 2096 (2) INFORMATION FOR SEQ ID NO:20: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: CDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:20: CATATGGCCG TCTCGCTGGG AGGAG 25 (2) INFORMATION FOR SEQ ID NO:21: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 19 base pairβ (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: CDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:21: GTTGGATTGC CGGTGAGCC 19 (2) INFORMATION FOR SEQ ID NO:22: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: CDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:22: CATATGGACG CCACCACCGG C 21 (2) INFORMATION FOR SEQ ID NO:23: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1506 base pairβ (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: CDNA (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 4..1464 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:24: CAT ATG GCC GTC TCG CTG GAG GAG CAG ATC TCC GCG ATG GAC GCC ACC 48 Met Ala Val Ser Leu Glu Glu Gin He Ser Ala Met Aβp Ala Thr 515 520 525 ACC GGC GAC TTC ACG GCG CTG CAG AAG GCG GTG AAG CAG ATG GCC ACC 96 Thr Gly Aβp Phe Thr Ala Leu Gin Lye Ala Val Lye Gin Met Ala Thr 530 535 540 AAG GCG GGC ACT GAG GGC CTG GTG CAC GGC ATC AAG AAC CCC GAC GTG 144 Lye Ala Gly Thr Glu Gly Leu Val Hie Gly He Lye Aβn Pro Aβp Val 545 550 555 CGC CAG CTG CTG ACC GAG ATC TTC ATG AAG GAC CCG GAG CAG CAG GAG 192 Arg Gin Leu Leu Thr Glu He Phe Met Lys Asp Pro Glu Gin Gin Glu 560 565 570 575 TTC ATG CAG GCG GTG CGC GAG GTG GCC GTC TCC CTG CAG CCC GTG TTC 240 Phe Met Gin Ala Val Arg Glu Val Ala Val Ser Leu Gin Pro Val Phe 580 585 590 GAG AAG CGC CCC GAG CTG CTG CCC ATC TTC AAG CAG ATC GTT GAG CCT 288 Glu Lys Arg Pro Glu Leu Leu Pro He Phe Lye Gin He Val Glu Pro 595 600 605 GAG CGC GTG ATC ACC TTC CGC GTG TCC TGG CTG GAC GAC GCC GGC AAC 336 Glu Arg Val He Thr Phe Arg Val Ser Trp Leu Aep Aβp Ala Gly Aβn 610 615 620 CTG CAG GTC AAC CGC GGC TTC CGC GTG CAG TAC TCG TCC GCC ATC GGC 384 Leu Gin Val Asn Arg Gly Phe Arg Val Gin Tyr Ser Ser Ala He Gly 625 630 635 CCC TAC AAG GGC GGC CTG CGC TTC CAC CCC TCC GTG AAC CTG TCC ATC 432 Pro Tyr Lys Gly Gly Leu Arg Phe His Pro Ser Val Asn Leu Ser He 640 645 650 655 ATG AAG TTC CTT GCC TTT GAG CAG ATC TTC AAG AAC AGC CTG ACC ACC 480 Met Lys Phe Leu Ala Phe Glu Gin He Phe Lys Asn Ser Leu Thr Thr 660 665 670 CTG CCC ATG GGC GGC GGC AAG GGC GGC TCC GAC TTC GAC CCC AAG GGC 528 Leu Pro Met Gly Gly Gly Lys Gly Gly Ser Asp Phe Asp Pro Lys Gly 675 680 685 AAG AGC GAC GCG GAG GTG ATG CGC TTC TGC CAG TCC TTC ATG ACC GAG 576 Lys Ser Asp Ala Glu Val Met Arg Phe Cyβ Gin Ser Phe Met Thr Glu 690 695 700 CTG CAG CGC CAC ATC AGC TAC GTG CAG GAC GTG CCC GCC GGC GAC ATC 624 Leu Gin Arg His He Ser Tyr Val Gin Aβp Val Pro Ala Gly Aβp He 705 710 715 GGC GTG GGC GCG CGC GAG ATT GGC TAC CTT TTC GGC CAG TAC AAG CGC 672 Gly Val Gly Ala Arg Glu He Gly Tyr Leu Phe Gly Gin Tyr Lye Arg 720 725 730 735 ATC ACC AAG AAC TAC ACC GGC GTG CTG ACC CCG AAG GGC CAG GAG TAT 720 He Thr Lye Aβn Tyr Thr Gly Val Leu Thr Pro Lye Gly Gin Glu Tyr 740 745 750 GGC GGC TCC GAG ATC CGC CCC GAG GCC ACC GGC TAC GGC GCC GTG CTG 768 Gly Gly Ser Glu He Arg Pro Glu Ala Thr Gly Tyr Gly Ala Val Leu 755 760 765 TTT GTG GAG AAC GTG CTG AAG GAC AAG GGC GAG AGC CTC AAG GGC AAG 816 Phe Val Glu Aβn Val Leu Lye Aep Lye Gly Glu Ser Leu Lye Gly Lye 770 775 780 CGC TGC CTG GTG TCT GGC GCG GGC AAC GTG GCC CAG TAC TGC GCG GAG 864 Arg Cyβ Leu Val Ser Gly Ala Gly Asn Val Ala Gin Tyr Cyβ Ala Glu 785 790 795 CTG CTG CTG GAG AAG GGC GCC ATC GTG CTG TCG CTG TCC GAC TCC CAG 912 Leu Leu Leu Glu Lye Gly Ala He Val Leu Ser Leu Ser Asp Ser Gin 800 805 810 815 GGC TAC GTG TAC GAG CCC AAC GGC TTC ACG CGC GAG CAG CTG CAG GCG 960 Gly Tyr Val Tyr Glu Pro Asn Gly Phe Thr Arg Glu Gin Leu Gin Ala 820 825 830 GTG CAG GAC ATG AAG AAG AAG AAC AAC AGC GCC CGC ATC TCC GAG TAC 1008 Val Gin Asp Met Lys Lys Lys Aen Aβn Ser Ala Arg He Ser Glu Tyr 835 840 845 AAG AGC GAC ACC GCC GTG TAT GTG GGC GAC CGC CGC AAG CCT TGG GAG 1056 Lye Ser Aβp Thr Ala Val Tyr Val Gly Aβp Arg Arg Lye Pro Trp Glu 850 855 860 CTG GAC TGC CAG GTG GAC ATC GCC TTC CCC TGC GCC ACC CAG AAC GAG 1104 Leu Asp Cyβ Gin Val Asp He Ala Phe Pro Cys Ala Thr Gin Asn Glu 865 870 875 ATC GAT GAG CAC GAC GCC GAG CTG CTG ATC AAG CAC GGC TGC CAG TAC 1152 He Aβp Glu His Aep Ala Glu Leu Leu He Lye Hie Gly Cyβ Gin Tyr 880 885 890 895 GTG GTG GAG GGC GCC AAC ATG CCC TCC ACC AAC GAG GCC ATC CAC AAG 1200 Val Val Glu Gly Ala Asn Met Pro Ser Thr Aβn Glu Ala He Hie Lye 900 905 910 TAC AAC AAG GCC GGC ATC ATC TAC TGC CCC GGC AAG GCG GCC AAC GCC 1248 Tyr Aβn Lye Ala Gly He He Tyr Cys Pro Gly Lys Ala Ala Asn Ala 915 920 925 GGC GGC GTG GCG GTC AGC GGC CTG GAG ATG ACC CAG AAC CGC ATG AGC 1296 Gly Gly Val Ala Val Ser Gly Leu Glu Met Thr Gin Aβn Arg Met Ser 930 935 940 CTG AAC TGG ACT CGC GAG GAG GTT CGC GAC AAG CTG GAG CGC ATC ATG 1344 Leu Asn Trp Thr Arg Glu Glu Val Arg Aβp Lys Leu Glu Arg He Met 945 950 955 AAG GAC ATC TAC GAC TCC GCC ATG GGG CCG TCC CGC AGA TAC AAT GTT 1392 Lys Asp He Tyr Asp Ser Ala Met Gly Pro Ser Arg Arg Tyr Aβn Val 960 965 970 975 GAC CTG GCT GCG GGC GCC AAC ATC GCG GGC TTC ACC AAG GTG GCT GAT 1440 Aβp Leu Ala Ala Gly Ala Aβn He Ala Gly Phe Thr Lye Val Ala Aβp 980 985 990 GCC GTC AAG GCC CAG GGC GCT GTT TAAGCTGCCC AGGCCCAAGC CACGGCTCAC 1494 Ala Val Lye Ala Gin Gly Ala Val 995 CGGCAATCCA AC 1506 (2) INFORMATION FOR SEQ ID NO:24: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 487 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:24: Met Ala Val Ser Leu Glu Glu Gin He Ser Ala Met Aβp Ala Thr Thr 1 5 10 15 Gly Asp Phe Thr Ala Leu Gin Lys Ala Val Lys Gin Met Ala Thr Lys 20 25 30 Ala Gly Thr Glu Gly Leu Val His Gly He Lys Asn Pro Asp Val Arg 35 40 45 Gin Leu Leu Thr Glu He Phe Met Lys Aep Pro Glu Gin Gin Glu Phe 50 55 60 Met Gin Ala Val Arg Glu Val Ala Val Ser Leu Gin Pro Val Phe Glu 65 70 75 80 Lye Arg Pro Glu Leu Leu Pro He Phe Lye Gin He Val Glu Pro Glu 85 90 95 Arg Val He Thr Phe Arg Val Ser Trp Leu Aβp Asp Ala Gly Asn Leu 100 105 110 Gin Val Aβn Arg Gly Phe Arg Val Gin Tyr Ser Ser Ala He Gly Pro 115 120 125 Tyr Lys Gly Gly Leu Arg Phe His Pro Ser Val Asn Leu Ser He Met 130 135 140 Lys Phe Leu Ala Phe Glu Gin He Phe Lys Asn Ser Leu Thr Thr Leu 145 150 155 160 Pro Met Gly Gly Gly Lys Gly Gly Ser Asp Phe Asp Pro Lye Gly Lye 165 170 175 Ser Aβp Ala Glu Val Met Arg Phe Cyβ Gin Ser Phe Met Thr Glu Leu 180 185 190 Gin Arg Hie He Ser Tyr Val Gin Aep Val Pro Ala Gly Aβp He Gly 195 200 205 Val Gly Ala Arg Glu He Gly Tyr Leu Phe Gly Gin Tyr Lys Arg He 210 215 220 Thr Lye Aβn Tyr Thr Gly Val Leu Thr Pro Lye Gly Gin Glu Tyr Gly 225 230 235 240 Gly Ser Glu He Arg Pro Glu Ala Thr Gly Tyr Gly Ala Val Leu Phe 245 250 255 Val Glu Asn Val Leu Lye Aβp Lys Gly Glu Ser Leu Lys Gly Lys Arg 260 265 270 Cyβ Leu Val Ser Gly Ala Gly Aβn Val Ala Gin Tyr Cyβ Ala Glu Leu 275 280 285 Leu Leu Glu Lye Gly Ala He Val Leu Ser Leu Ser Aβp Ser Gin Gly 290 295 300 Tyr Val Tyr Glu Pro Aβn Gly Phe Thr Arg Glu Gin Leu Gin Ala Val 305 310 315 320 Gin Aβp Met Lye Lye Lye Asn Asn Ser Ala Arg He Ser Glu Tyr Lys 325 330 335 Ser Asp Thr Ala Val Tyr Val Gly Asp Arg Arg Lys Pro Trp Glu Leu 340 345 350 A β p Cys Gin Val Aβp He Ala Phe Pro Cys Ala Thr Gin Asn Glu He 355 360 365 Asp Glu Hie Aβp Ala Glu Leu Leu He Lye Hie Gly Cyβ Gin Tyr Val 370 375 380 Val Glu Gly Ala Aβn Met Pro Ser Thr Aβn Glu Ala He Hie Lye Tyr 385 390 395 400 Aβn Lye Ala Gly He He Tyr Cyβ Pro Gly Lye Ala Ala Aβn Ala Gly 405 410 415 Gly Val Ala Val Ser Gly Leu Glu Met Thr Gin Aβn Arg Met Ser Leu 420 425 430 Aβn Trp Thr Arg Glu Glu Val Arg Aep Lye Leu Glu Arg He Met Lye 435 440 445 Aβp He Tyr Aβp Ser Ala Met Gly Pro Ser Arg Arg Tyr Aβn Val Aβp 450 455 460 Leu Ala Ala Gly Ala Aβn He Ala Gly Phe Thr Lys Val Ala Asp Ala 465 470 475 480 Val Lys Ala Gin Gly Ala Val 485 (2) INFORMATION FOR SEQ ID NO:25: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1473 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: CDNA (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 4..1431 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:25: CAT ATG GAC GCC ACC ACC GGC GAC TTC ACG GCG CTG CAG AAG GCG GTG 48 Met Asp Ala Thr Thr Gly Asp Phe Thr Ala Leu Gin Lys Ala Val 490 495 500 AAG CAG ATG GCC ACC AAG GCG GGC ACT GAG GGC CTG GTG CAC GGC ATC 96 Lys Gin Met Ala Thr Lye Ala Gly Thr Glu Gly Leu Val Hie Gly He 505 510 515 AAG AAC CCC GAC GTG CGC CAG CTG CTG ACC GAG ATC TTC ATG AAG GAC 144 Lye Aβn Pro Aβp Val Arg Gin Leu Leu Thr Glu He Phe Met Lye Aβp 520 525 530 CCG GAG CAG CAG GAG TTC ATG CAG GCG GTG CGC GAG GTG GCC GTC TCC 192 Pro Glu Gin Gin Glu Phe Met Gin Ala Val Arg Glu Val Ala Val Ser 535 540 545 550 CTG CAG CCC GTG TTC GAG AAG CGC CCC GAG CTG CTG CCC ATC TTC AAG 240 Leu Gin Pro Val Phe Glu Lye Arg Pro Glu Leu Leu Pro He Phe Lye 555 560 565 CAG ATC GTT GAG CCT GAG CGC GTG ATC ACC TTC CGC GTG TCC TGG CTG 288 Gin He Val Glu Pro Glu Arg Val He Thr Phe Arg Val Ser Trp Leu 570 575 580 GAC GAC GCC GGC AAC CTG CAG GTC AAC CGC GGC TTC CGC GTG CAG TAC 336 Aβp Aβp Ala Gly Aβn Leu Gin Val Aβn Arg Gly Phe Arg Val Gin Tyr 585 590 595 TCG TCC GCC ATC GGC CCC TAC AAG GGC GGC CTG CGC TTC CAC CCC TCC 384 Ser Ser Ala He Gly Pro Tyr Lye Gly Gly Leu Arg Phe His Pro Ser 600 605 610 GTG AAC CTG TCC ATC ATG AAG TTC CTT GCC TTT GAG CAG ATC TTC AAG 432 Val Asn Leu Ser He Met Lys Phe Leu Ala Phe Glu Gin He Phe Lys 615 620 625 630 AAC AGC CTG ACC ACC CTG CCC ATG GGC GGC GGC AAG GGC GGC TCC GAC 480 Asn Ser Leu Thr Thr Leu Pro Met Gly Gly Gly Lye Gly Gly Ser Aβp 635 640 645 TTC GAC CCC AAG GGC AAG AGC GAC GCG GAG GTG ATG CGC TTC TGC CAG 528 Phe Aβp Pro Lye Gly Lye Ser Aβp Ala Glu Val Met Arg Phe Cyβ Gin 650 655 660 TCC TTC ATG ACC GAG CTG CAG CGC CAC ATC AGC TAC GTG CAG GAC GTG 576 Ser Phe Met Thr Glu Leu Gin Arg Hie He Ser Tyr Val Gin Aβp Val 665 670 675 CCC GCC GGC GAC ATC GGC GTG GGC GCG CGC GAG ATT GGC TAC CTT TTC 624 Pro Ala Gly Aβp He Gly Val Gly Ala Arg Glu He Gly Tyr Leu Phe 680 685 690 GGC CAG TAC AAG CGC ATC ACC AAG AAC TAC ACC GGC GTG CTG ACC CCG 672 Gly Gin Tyr Lye Arg He Thr Lye Aβn Tyr Thr Gly Val Leu Thr Pro 695 700 705 710 AAG GGC CAG GAG TAT GGC GGC TCC GAG ATC CGC CCC GAG GCC ACC GGC 720 Lye Gly Gin Glu Tyr Gly Gly Ser Glu He Arg Pro Glu Ala Thr Gly 715 720 725 TAC GGC GCC GTG CTG TTT GTG GAG AAC GTG CTG AAG GAC AAG GGC GAG 768 Tyr Gly Ala Val Leu Phe Val Glu Aβn Val Leu Lye Aβp Lys Gly Glu 730 735 740 AGC CTC AAG GGC AAG CGC TGC CTG GTG TCT GGC GCG GGC AAC GTG GCC 816 Ser Leu Lys Gly Lys Arg Cys Leu Val Ser Gly Ala Gly Asn Val Ala 745 750 755 CAG TAC TGC GCG GAG CTG CTG CTG GAG AAG GGC GCC ATC GTG CTG TCG 864 Gin Tyr Cyβ Ala Glu Leu Leu Leu Glu Lys Gly Ala He Val Leu Ser 760 765 770 CTG TCC GAC TCC CAG GGC TAC GTG TAC GAG CCC AAC GGC TTC ACG CGC 912 Leu Ser Aep Ser Gin Gly Tyr Val Tyr Glu Pro Aβn Gly Phe Thr Arg 775 780 785 790 GAG CAG CTG CAG GCG GTG CAG GAC ATG AAG AAG AAG AAC AAC AGC GCC 960 Glu Gin Leu Gin Ala Val Gin Aβp Met Lye Lye Lye Aβn Aβn Ser Ala 795 800 805 CGC ATC TCC GAG TAC AAG AGC GAC ACC GCC GTG TAT GTG GGC GAC CGC 1008 Arg He Ser Glu Tyr Lye Ser Aβp Thr Ala Val Tyr Val Gly Aβp Arg 810 815 820 CGC AAG CCT TGG GAG CTG GAC TGC CAG GTG GAC ATC GCC TTC CCC TGC 1056 Arg Lys Pro Trp Glu Leu Aβp Cyβ Gin Val Aβp He Ala Phe Pro Cys 825 830 835 GCC ACC CAG AAC GAG ATC GAT GAG CAC GAC GCC GAG CTG CTG ATC AAG 1104 Ala Thr Gin Aβn Glu He Aβp Glu Hie Asp Ala Glu Leu Leu He Lys 840 845 850 CAC GGC TGC CAG TAC GTG GTG GAG GGC GCC AAC ATG CCC TCC ACC AAC 1152 Hie Gly Cyβ Gin Tyr Val Val Glu Gly Ala Aβn Met Pro Ser Thr Asn 855 860 865 870 GAG GCC ATC CAC AAG TAC AAC AAG GCC GGC ATC ATC TAC TGC CCC GGC 1200 Glu Ala He His Lye Tyr Aβn Lye Ala Gly He He Tyr Cyβ Pro Gly 875 880 885 AAG GCG GCC AAC GCC GGC GGC GTG GCG GTC AGC GGC CTG GAG ATG ACC 1248 Lye Ala Ala Aen Ala Gly Gly Val Ala Val Ser Gly Leu Glu Met Thr 890 895 900 CAG AAC CGC ATG AGC CTG AAC TGG ACT CGC GAG GAG GTT CGC GAC AAG 1296 Gin Aβn Arg Met Ser Leu Aβn Trp Thr Arg Glu Glu Val Arg Aβp Lye 905 910 915 CTG GAG CGC ATC ATG AAG GAC ATC TAC GAC TCC GCC ATG GGG CCG TCC 1344 Leu Glu Arg He Met Lye Aβp He Tyr Aβp Ser Ala Met Gly Pro Ser 920 925 930 CGC AGA TAC AAT GTT GAC CTG GCT GCG GGC GCC AAC ATC GCG GGC TTC 1392 Arg Arg Tyr Aβn Val Asp Leu Ala Ala Gly Ala Asn He Ala Gly Phe 935 940 945 950 ACC AAG GTG GCT GAT GCC GTC AAG GCC CAG GGC GCT GTT TAAGCTGCCC 1441 Thr Lys Val Ala Asp Ala Val Lys Ala Gin Gly Ala Val 955 960 AGGCCCAAGC CACGGCTCAC CGGCAATCCA AC 1473 (2) INFORMATION FOR SEQ ID NO:26: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 476 amino acids (B) TYPE: amino acid (D) TOPOLOGY: 1inear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:26: Met Asp Ala Thr Thr Gly Asp Phe Thr Ala Leu Gin Lye Ala Val Lye 1 5 10 15 Gin Met Ala Thr Lys Ala Gly Thr Glu Gly Leu Val His Gly He Lye 20 25 30 Aβn Pro Aβp Val Arg Gin Leu Leu Thr Glu He Phe Met Lye Aβp Pro 35 40 45 Glu Gin Gin Glu Phe Met Gin Ala Val Arg Glu Val Ala Val Ser Leu 50 55 60 Gin Pro Val Phe Glu Lye Arg Pro Glu Leu Leu Pro He Phe Lye Gin 65 70 75 80 He Val Glu Pro Glu Arg Val He Thr Phe Arg Val Ser Trp Leu Aβp 85 90 95 Aβp Ala Gly Aβn Leu Gin Val Aβn Arg Gly Phe Arg Val Gin Tyr Ser 100 105 110 Ser Ala He Gly Pro Tyr Lye Gly Gly Leu Arg Phe Hie Pro Ser Val 115 120 125 Aβn Leu Ser He Met Lye Phe Leu Ala Phe Glu Gin He Phe Lye Aen 130 135 140 Ser Leu Thr Thr Leu Pro Met Gly Gly Gly Lye Gly Gly Ser Aβp Phe 145 150 155 160 Asp Pro Lys Gly Lys Ser Asp Ala Glu Val Met Arg Phe Cys Gin Ser 165 170 175 Phe Met Thr Glu Leu Gin Arg His He Ser Tyr Val Gin Asp Val Pro 180 185 190 Ala Gly Asp He Gly Val Gly Ala Arg Glu He Gly Tyr Leu Phe Gly 195 200 205 Gin Tyr Lye Arg He Thr Lye Aen Tyr Thr Gly Val Leu Thr Pro Lye 210 215 220 Gly Gin Glu Tyr Gly Gly Ser Glu He Arg Pro Glu Ala Thr Gly Tyr 225 230 235 240 Gly Ala Val Leu Phe Val Glu Aen Val Leu Lys Aβp Lye Gly Glu Ser 245 250 255 Leu Lye Gly Lye Arg Cyβ Leu Val Ser Gly Ala Gly Aβn Val Ala Gin 260 265 270 Tyr Cye Ala Glu Leu Leu Leu Glu Lye Gly Ala He Val Leu Ser Leu 275 280 285 Ser Aβp Ser Gin Gly Tyr Val Tyr Glu Pro Aen Gly Phe Thr Arg Glu 290 295 300 Gin Leu Gin Ala Val Gin Aβp Met Lye Lys Lys Asn Aβn Ser Ala Arg 305 310 315 320 He Ser Glu Tyr Lys Ser Asp Thr Ala Val Tyr Val Gly Asp Arg Arg 325 330 335 Lys Pro Trp Glu Leu Asp Cys Gin Val Asp He Ala Phe Pro Cys Ala 340 345 350 Thr Gin Aβn Glu He Aβp Glu Hie Aβp Ala Glu Leu Leu He Lye Hie 355 360 365 Gly Cye Gin Tyr Val Val Glu Gly Ala Aβn Met Pro Ser Thr Aβn Glu 370 375 380 Ala He Hie Lye Tyr Aβn Lye Ala Gly He He Tyr Cyβ Pro Gly Lye 385 390 395 400 Ala Ala Aβn Ala Gly Gly Val Ala Val Ser Gly Leu Glu Met Thr Gin 405 410 415 Aβn Arg Met Ser Leu Aβn Trp Thr Arg Glu Glu Val Arg Aβp Lye Leu 420 425 430 Glu Arg He Met Lye Asp He Tyr Aβp Ser Ala Met Gly Pro Ser Arg 435 440 445 Arg Ty r Aen Val Asp Leu Ala Ala Gly Ala Asn He Ala Gly Phe Thr 450 455 460 Lys Val Ala Asp Ala Val Lys Ala Gin Gly Ala Val 465 470 475

Claims: Claims 1. A polynucleotide comprising a nucleotide sequence encoding an amino acid sequence seleαed from the group consisting of SEQ ID NO. 2, SEQ ID NO. 4, SEQ ID NO. 24, and SEQ ID NO. 26, or a fragment or mutant thereof. 2. A polynucleotide comprising a nucleotide sequence seleαed from the group consisting of SEQ ID NO. 1, SEQ ID NO. 3, SEQ ID NO. 7, SEQ ID NO. 8, SEQ ID NO. 9, SEQ ID NO. 10, SEQ ID NO. 11, SEQ ID NO. 12, SEQ ID NO. 13, SEQ ID NO. 14, SEQ ID NO.. 15, SEQ ID NO. 16, SEQ ID NO. 17, SEQ ID NO. 18, SEQ ID NO. 19, SEQ ID NO. 20, SEQ ID NO. 21, SEQ ID NO. 22, SEQ ID NO. 23, and SEQ ID NO. 25, or a fragment or mutant thereof. 3. The polynucleotide, according to claim 2, comprising a nucleotide sequence selected from the group consisting of the nucleotide sequences shown in SEQ ID NO. 1, SEQ ID NO. 3, SEQ ID NO. 23, and SEQ ID NO. 25, or a fragment or mutant thereof. 4. The polynucleotide, according to claim 2, forming a chimeric gene capable of expressing in plant cells, said gene comprising a plant expressible promoter operably linked to the polynucleotide. 5. The polynucleotide, according to claim 2, wherein said polynucleotide is operably linked to a plant polyadenylation sequence. 6. The polynucleotide, according to claim 2, comprising at least one nucleotide sequence encoding an NADP-GDH alpha-subunit and at least one nucleotide sequence encoding an NADP- GDH beta-subunit. 7. The polynucleotide, according to claim 6, wherein said polynucleotide further comprises a promoter for said polynucleotide encoding an NADP-GDH alpha-subunit and an NADP-GDH beta- subunit. 8. The polynucleotide, according to claim 7, wherein the promoter is different for the alpha- subunit and the beta-subunit. 9. The polynucleotide, according to claim 7, wherein said promoter has differential activity for the alpha and beta-subunits. 10. The polynucleotide, according to claim 6, comprising a nucleotide sequence seleαed from the group consisting of SEQ ID NO. 1 and SEQ ID NO. 23 and a nucleotide sequence selected from the group consisting of SEQ ID NO. 3 and SEQ ED NO. 25. 11. A transformed host cell comprising a polynucleotide encoding an amino acid sequence selected from the group consisting of SEQ ID NO. 2, SEQ ID NO. 4, SEQ ID NO. 24, and SEQ D NO. 26, or a fragment or mutant thereof. 12. The transformed host cell, according to claim 11, wherein said polynucleotide encodes an amino acid sequence seleαed from the group consisting of SEQ ED NO. 2 and SEQ ED NO. 24 and an amino acid sequence selected from the group consisting of SEQ ID NO. 4 and SEQ ID NO. 26. 13. The transformed host cell, according to claim 11, wherein said polynucleotide comprises a nucleotide sequence seleαed from the group consisting of the nucleotide sequences shown in SEQ ID NO. 1, SEQ ID NO. 3, SEQ ID NO. 23, and SEQ ID NO. 25. 14. The transformed host cell, according to claim 13, comprising a nucleotide sequence selected from the group consisting of SEQ ID NO. 1 and SEQ ID NO. 23 and a nucleotide sequence seleαed from the group consisting of SEQ ID NO. 3 and SEQ ED NO. 25. 15. A method for modulating nitrogen metabolism in plant cells, said method comprising transforming said plant cells to comprise a polynucleotide having a nucleotide sequence selected from the group consisting of SEQ ID NO. 1, SEQ ED NO. 3, SEQ ID NO. 23, and SEQ ID NO. 25, or a fragment or mutant thereof. 16. The method, according to claim 15, wherein said polynucleotide has a nucleotide sequence encoding at least one NADP-GDH alpha-subunit and at least one nucleotide sequence encoding an NADP-GDH beta-subunit. 17. The method, according to claim 16, wherein said polynucleotide comprises a nucleotide sequence seleαed from the group consisting of SEQ ID NO. 1 and SEQ ID NO. 23 and a nucleotide sequence selected from the group consisting of SEQ ID NO. 3 and SEQ ID NO. 25. 18. The method, according to claim 15, wherein said nitrogen modulation comprises increasing the assimilation of inorganic nitrogen into organic nitrogen. 19. The method, according to claim 15, wherein said polynucleotide is operably linked to a plant expressible promoter. 20. The method, according to claim 15, wherein said polynucleotide is operably linked to a plant polyadenylation sequence. 21. A method for modulating the properties of a plant, said method comprising expressing in said plant a polynucleotide encoding the amino acid sequence seleαed from the group consisting of SEQ ID NO. 2, SEQ ID NO. 4, SEQ ID NO. 24, and SEQ ID NO. 26, or a fragment or mutant thereof. 22. The method, according to claim 21, wherein said polynucleotide encodes a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO. 2 and SEQ ID NO. 24 and an amino acid sequence seleαed from the group consisting of SEQ ID NO. 4 and SEQ ID NO. 26. 23. The method, according to claim 21, wherein said modulation includes increasing crop yield, altering ammomum assimilation, altering osmotic stress tolerance, or altering composition of the plant. 24. A method for expressing GDH having kinetic properties of NADP-GDH hexamers, said method comprising employing the amino terminal sequence of a subunit of said hexamer, wherein said amino terminal sequence is seleαed from the group consisting of SEQ ID NO. 5 and SEQ ID NO. 6. 25. A polypeptide comprising an amino acid sequence seleαed from the group consisting of SEQ ID NO. 2, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 24, and SEQ ID NO. 26, or a fragment or mutant thereof. 26. The polypeptide, according to claim 25, comprising an amino acid sequence seleαed from the group consisting of SEQ ID NO. 2, SEQ ID NO. 4, SEQ ID NO. 24, and SEQ DO NO. 26, or a fragment or mutant thereof. 27. The polypeptide, according to claim 26, wherein said polypeptide comprises the amino acid sequence of SEQ ID NO. 2 or a fragment or mutant thereof. 28. The polypeptide, according to claim 26, wherein said polypeptide comprises the amino acid sequence of SEQ ID NO. 4 or a fragment or mutant thereof. 29. The polypeptide, according to claim 26, wherein said polypeptide comprises the amino acid sequence of SEQ ID NO. 24. 30. The polypeptide, according to claim 26, wherein said polypeptide comprises the amino acid sequence of SEQ ED NO. 26. 31. The polypeptide, according to claim 25, forming an amino terminal of a beta-nicotinamide adenine dinucleotide phosphate-glutamate dehydrogenase subunit comprising an amino acid sequence selected from the group consisting of SEQ ID NO. 5 and SEQ ED NO. 6. 32. A polypeptide comprising a plurality of subunits, said polypeptide having at least one NADP-GDH alpha-subunit and at least one NADP-GDH beta-subunit. 33. The polypeptide, according to claim 32, wherein the alpha-subunit comprises a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO. 2 and SEQ ED NO. 24 or a fragment or mutant thereof. 34. The polypeptide, according to claim 32, wherein said beta-subunit comprises a polypeptide seleαed from the group consisting of SEQ ID NO. 4 and SEQ ID NO. 26. 35. The polypeptide, according to claim 32, wherein the polypeptide is a heterohexamer. 36. The polypeptide, according to claim 35, wherein the polypeptide comprises at least two beta-subunits. 37. The polypeptide, according to claim 36, wherein the polypeptide comprises two to five beta-subunits. 38. The polypeptide, according to claim 37, wherein the polypeptide comprises three beta- subunits. 39. A chloroplast-transit peptide having an amino acid sequence comprising the amino acid terminus seleαed from the group consisting of SEQ ID NO. 2 and SEQ ID NO. 4, or a fragment thereof. 40. A polynucleotide sequence encoding a chloroplast-transit peptide, said nucleotide sequence comprising a 5 '-terminus sequence seleαed from SEQ ID NO. 1 and SEQ ID NO. 3.

Inventors: MILLER PHILIP, SCHMIDT ROBERT R, MILLER, PHILIP, SCHMIDT, ROBERT, R.
Applicants: UNIV FLORIDA, UNIVERSITY OF FLORIDA
Application year: 1996
Main classification: C12N15
IPC codes: C07K14, C12N5, C12N9, C12N15